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 Summary
In the early 1990’s the ready access to CT images for treatment planning, the advent of 
new beam limiting devices and electronic imaging technology on the external radiation 
treatment machine, challenged the existing methods and modes of working in a busy 
radiotherapy department. This spurred a comprehensive research activity in the Norwegian 
Radium Hospital with emphasis on image processing, analysis and communication. The 
aim was to improve the geometric and dosimetric precision of radiotherapy.   
The research of the present thesis has addressed imaging in the Beams Eye View 
(BEV) geometry. In this geometry the investigations carried out were focused on the 
formation of digitally reconstructed radiograms (DRRs); methods for semi-automated 
comparison of electronic portal images (EPIs), acquired on the patient exit side during 
treatment, with the corresponding DRR; analysis of the geometric performance of the beam 
limiting devices; and the assessment of patient dose from the exposure of the imaging 
devices. These efforts were initiated shortly after the introduction of each new technology.   
More specifically the present thesis treats the creation of full and limited range 
DRRs from CT, PET, and MR images with a quality tailored for the purpose of 
multimodality visualization and image registration.  Furthermore, methods for extraction of 
image features from low contrast EPIs to facilitate automatic matching with DRRs were 
investigated and implemented. Another important activity has been to investigate and put 
into use methods for monitoring the MLC performance. This has been achieved by 
developing methods to accurately identify the positions of the individual leaves from portal 
images.  
The methods developed were embedded into a hospital verification and record 
system. Results from the image comparisons were used in a statistically based analysis to 
correct the patient set-up. The lessons learned from use of the image processing tools have 
provided the confidence needed to introduce new advanced treatment techniques.  
This comprehensive system has, since the introduction, been used to analyse more 
than 200 000 portal images acquired at repeated treatment sessions on 6 treatment units 
creating a large database of patient set-up deviation data. The use of this database and the 
interplay with the different professions involved has been instrumental to our 
understanding of the nature of the various uncertainties in play and how to assess and 
mitigate these uncertainties. This has facilitated sound decision making in everyday 
routine, and the clinical “best practice” has moved from the cm scale to the mm scale.   
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1. Introduction
1.1. Cancer and the principles of radiobiology in radiotherapy 
Cancer is the term used for diseases where the cells of the body become abnormal and divide 
without control ultimately leading to the formation of tumours. The origins of cancer are not 
fully understood, but there are a number of known carcinogens that are involved in causing 
cancer. These are commonly divided into three classes: chemical carcinogens such as dioxins 
and tobacco smoke, physical carcinogens such as ionizing and ultraviolet radiation, and 
biological carcinogens such as certain viruses. The carcinogens inflict damages or changes to 
the DNA of a cell, producing mutations that may initiate carcinogenesis. When this happens, 
cells do not die from programmed cell death (apoptosis), and new cells form without being 
needed (inactivation of tumour suppressor genes). Cancer cells may invade nearby tissues and 
spread throughout the body via the bloodstream and lymphatic system (metastasis).  
In the Norwegian population of 4.9 million inhabitants, 27520 new cases of cancer 
were registered in 2009: 54% were among men and 46% among women. Between the five 
year periods 2000-04 and 2005-09, the incidence rate increased by 7% in men and 3% in 
women. There are however large variations between the different cancers [1]. The stronger 
focus on cancer from the health care system and increased attention regarding cancer from the 
patient, screening programs, as well as an increased quality of treatment have improved the 
survival. The latter can be illustrated by the number of Norwegians that are alive after having 
had a least one cancer diagnosis: This number increased from 140 000 in 1999 to nearly 
200 000 in 2009. An improved survival is observed within all the four major cancers: breast, 
prostate, lung and colorectal cancer.  
Radiotherapy is next to surgery and chemotherapy the major treatment option for 
cancer. Around 40-45% of cancer patients will require radiotherapy at some point during their 
disease – either as the sole treatment modality or in combination with surgery and/or 
chemotherapy. There is a delicate balance between the anticipated control of the tumour and 
the complications inflicted on the normal tissue for a given radiation dose. This balance is 
illustrated in figure 1 where a typical example of the Tumour Control Probability (TCP) and 
Normal Tissue Complication Probability (NTCP) as functions of cumulative dose, are plotted. 
Increasing the cumulative radiation dose increases the local control (i.e. TCP), but will at the 
same time increase the risk of normal tissue damage (i.e. NTCP). The term therapeutic
window describes the difference between the tumour control dose and the normal tissue 
tolerance dose [2].  In other words, there must be a dose difference between the two curves for 
 radiotherapy to be beneficial. Evidently, the larger the separation, the more favourable 
radiotherapy is. The therapeutic index gives the tumour response for a fixed level of normal 
tissue damage [2]. In curative cancer treatment, the key issue is to find ways of improving the 
therapeutic index. The relative change in this index – and to which cost - is often used to 
evaluate whether a new treatment procedure would be beneficial or not.            
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Figure 1 Illustration of a situation where the therapeutic window is in 
favour of radiotherapy: For a given radiation schedule and technique, 
a high probability of tumour of control (TCP) can be reached at a dose 
level that does not inflict severe normal tissue complications (NTCP). 
The therapeutic index (TI) gives the tumour response for a fixed 
probability of normal tissue damage (e.g. 5%). 
 
 For many cancers the therapeutic window appears to be very narrow. The history of 
radiotherapy with a curative intent has demonstrated that it is a very demanding task to 
administer total cumulative doses that can provide the desired level of tumour control without 
inflicting intolerable levels of normal tissue damage. The tumour control observed in a patient 
population for a given type of radiation treatment is hardly ever “100%”.  In fact that as many 
as 18% of cancer patients are likely to die with, and partly from, locoregional treatment 
failures [3]. This large number clearly illustrates the importance of improving the therapeutic 
index. Improving the dosimetric and geometric precision of external beam radiotherapy is 
important to achieve this goal because higher precision can increase the therapeutic index. 
This is the essence of the presented thesis. 
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 1.2. The Beam’s Eye View in radiotherapy 
External beam radiation therapy (EBRT) rests on the combined utilization of a) the 
armamentory of medical imaging modalities to produce three dimensional image volumes that 
represent different properties of the tissues, and b) a nearly point-formed source of high 
energy X-rays, electrons or heavier charges particles. Imaging modalities in common use are 
Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Positron Emission 
tomography (PET) and recent reviews of their roles in radiotherapy are given by P. Evans [4] 
and U. Nestle et al  [5].  
A prerequisite for treatment success is high sensitivity in the delineation of the tumour 
and accuracy in the subsequent irradiation of the tissue, i.e. the dose deposited and the extent 
of the tumour must coincide at all treatment sessions. To assure and maintain the desired 
geometric and dosimetric accuracy as well as precision, the Beam’s Eye View (BEV) and 
related imaging applications have played instrumental roles in clinical practice since the dawn 
of radiotherapy; from the early 80’s also utilized within the framework of digital imaging in 
radiotherapy [6-11]. 
The BEV facilitates an accurate one-point perspective projection of 3- or even 4-
dimensional image data sets. The position of the beam source is utilized as vanishing point 
defining a conical geometry identical to that of the treatment beam. The BEV therefore lends 
itself to the creation of accurate 2-dimensional renderings of patient anatomy suitable for use 
in treatment planning in particular. Looking along the beam, either by integrating information 
or by extracting relevant parameters from the volumetric image information, a condensed 
overview of the disease extension as well as the presence of critical tissues along that beam, is 
provided. Hence images created using the BEV perspective provide an intuitive basis for the 
delineation of target volumes and the subsequent shaping of the fields to be used for 
treatment.  
Historically the BEV notion has been exploited on the treatment simulator where the 
combined use of an X-ray image intensifier to produce a live image feed, the exposure of a 
radiographic film, and possibly clinical palpation, allowed for the manual formation of 
treatment fields. A typical example of a simulator image is found in panel A of Figure 2 
including the outline of the treatment field.    
In modern radiotherapy planning the borders of each single radiation field can be 
derived from a circumscription of the Gross Tumour Volume (GTV) [12] as depicted in the 
BEV, with a polygon shaped structure. The projections of these polygons into the body will 
define for each treatment session the volume actually treated and the dose distribution inside 
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 it. This perception is valid for the most simplistic types of treatments such as the use of a 
single field to the most sophisticated types of treatments involving volumetric intensity 
modulated arc therapy (refer to section 1.6).  
 Likewise, the advent of new imaging technology and digital image processing methods 
in the beams eye view provide valuable means to reveal and characterise a number of 
properties vital to the quality of treatment execution. These include the geometrical precision 
of patient set-up and treatment unit mechanics, as well as the precision of the treatment beam 
fluence and the dose delivered in the patient.     
1.3. Digitally Reconstructed Radiograms 
In radiotherapy planning an important BEV application is the creation of the Digitally 
Reconstructed Radiogram (DRR) [8, 13-16]. The DRR is formed by integrating the image 
voxel values along the paths of divergent rays that emerge from a common focus and hit an 
imaginary detector plane at the centres of each detector (image) pixel. By selecting the beam 
source as focus point, the DRR and BEV geometries coincide. A novel algorithm for the 
creation and exploitation of DRRs are presented in Paper I with a few extensions 
demonstrated in section 3.10 of this thesis. A typical example is found in panel B of Figure 2.   
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Figure 2 Illustration f typical BEV image types applied in the early development of image based set-up 
verification (upper row), and their corresponding binary templates used for image registration and set-up 
verification (lower row):  Panel A shows a digitized simulator film and D the corresponding binary template. 
Panel B shows a Digitally Reconstructed Radiogram (DRR) and E the corresponding binary template. Panel C 
shows an Electronic Portal Image (EPI) and F the corresponding binary template.
After treatment planning has been carried out, the real irradiated volume is defined by 
the number, shapes, and directions of the beams. The relationship between this volume and 
the tumour is readily conceived by means of the DRR. With the advent of sophisticated 3-
dimensional imaging, the DRR images may comprise a superposition of a multitude of disease 
related aspects vital to the potential success of the treatment plan being designed, ranging 
from tumour extent, its localisation and elasticity with respect to the patient skin, to tumour 
physiological characteristics that may stem from for instance PET or functional MR images 
(diffusion, perfusion, hypoxia). Furthermore the DRRs can visualize various technical aspects 
of the treatment plan as for example the individual beamlets used to modulate the intensities 
of the beams, the resulting dose distribution in the patient in a slice perpendicular to the beam, 
and the temporary location and movement of beam shaping devices. In addition, the DRRs 
facilitate a synoptic display and visual verification of the use of safety margins around the 
treatment target and organs at risk; margins that are appended to encompass various 
uncertainties related to planning and treatment execution. The algorithm and software 
described in Paper I can be used to realize many of these displays by making possible a 
combination of planning and imaging information from different modalities. 
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 1.4. Electronic Portal Images
Another key use of the BEV geometry is found in portal imaging and the formation of the 
electronic portal image (EPI) in particular [17]. A portal image usually denotes an image 
acquired using the radiotherapy beam. This image can be used to verify the patient set-up 
during treatment. Historically, portal images were created from the exposure of radiographic 
films located on the beam’s exit side of the patient. During the 90’s electronic portal imaging 
devices (EPIDs) were invented. These devices have by and large replaced the use of films and 
exhibit several advantages compared with films. Various types of EPIDs have been 
developed, based on different optical and x-ray detector systems [18].   
First of all EPIDs generate high resolution digital images of high quality that are 
immediately accessible at the treatment unit via dedicated image display and processing 
software. This allows for on-line patient set-up error detection and correction as well as more 
comprehensive imaging regimes to be implemented, both during the treatment session as well 
as throughout the course of treatment. To start with, EPIs thus replaced portal films as a 
means to measure the localisation of the patient anatomy with respect to beam edges, i.e. to 
ensure that the tumour is indeed being irradiated taking the applied margins into account. The 
processing and analysis of EPIs for the detection, geometric control and verification of both 
the beam limiting devices as well as the set-up of the patient during external beam therapy, 
has been a major development activity within the present work ([19], Paper II and III). This 
work resulted in a commercially available product marketed under the acronym IBV (Image 
Based Verification, Nucletron BV).  
Another important quality assurance aspect of radiotherapy is to determine the dose 
delivered to the patient during treatment. Quickly after the advent of EPIDs, the idea of portal 
dose imaging was investigated by several research groups. It was early on shown that EPIDs, 
and EPIDs made from amorphous silicon (a-Si) in particular, can act as convenient tools that 
can comply with the requirements of a dosimeter [20-26]. In this dissertation, some concepts 
of EPID dosimetry and a method for estimating transmitted dose from EPIs, or rather Portal 
Dose Images (PDIs) were studied in Paper VI.    
EPIDs are usually manufactured as an integrated part of the treatment machine. This 
makes image acquisition and assessment a lot easier and more efficient compared with films. 
The advent of EPIDs has therefore stimulated an evolving research activity in designing and 
developing EPI processing and analysis methods. This effort has continued to date and paved 
the way for the concepts of Image Guided Radiotherapy [27-28]. 
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 1.5. Imaging in the Beams Eye View of MR and PET   
Recently, MR scanners dedicated for radiotherapy treatment planning have been introduced. 
The superior soft tissue contrast of MRI over CT makes this imaging modality particularly 
appealing as delineation of tumours presumably can be carried out more accurately. This has 
created a desire to develop methods to calculate dose distributions based on MR images alone 
in order to supersede the traditional planning CT [29-33]. The dosimetric accuracy of this 
approach for the radiation therapy planning of prostate cancer was investigated in Paper VIII. 
Albeit MR images are well suited for planning purposes, full volumetric projection DRRs of 
MRI data do not result in images well suited for BEV display of anatomical structures of 
interest. The algorithm presented in Paper I addresses this issue by enabling range limited 
projections that allow for the visualization of tumour outlines in MRI based DRR (see section 
3.10). 
 As with MRI, PET scanning has over the past decade emerged to become a valuable 
imaging modality that can provide both anatomical and biological tumour information of 
importance to radiotherapy planning [5, 34-36]. In conventional PET diagnostics, the 
Maximum Intensity Projection (MIP) has been used to create parallel beam 2D projections of 
the tumour. Evidently, the conical projection geometry is desirable for tumour visualization in 
radiotherapy planning. Hence, divergent beam MIPs are needed and this was investigated and 
realized by the algorithm of Paper I.  
1.6. Radiotherapy with a linear particle accelerator  
Radiation therapy eradicates tumour cells by depositing ionizing radiation energy into the 
patient`s body. The imparted energy (radiation dose) can damage the cells such that they loose 
their ability to reproduce. The probability of achieving such a response increases with dose. 
Evidently, the radiation directed at the tumour cells, also affect the normal tissues along the 
radiation path. The key intent of radiotherapy is therefore to deposit an adequate radiation 
dose in the tumour cells and at the same time keep the dose to normal tissue at an acceptable 
level - a demanding task especially in cases of deep-seated tumours.  
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Figure 3 An outline of the design of a typical linear accelerator (Varian Clinac) including the wave guide 
for acceleration of electrons, bending magnets and target for bremsstrahlung generation, beam flattening 
and beam shaping devices including a multi leaf collimator MLC (right) (Varian Medical Systems)
 
The work horse of external beam radiotherapy used to realize this aim is the linear 
particle accelerator (linac) with an install base of more than 8000 world wide [37]. This L-
shaped device (gantry) is designed to produce x-rays of typical energies in the range 4 MV to 
25 MV. This is achieved by first accelerating electrons to near light speed through a series of 
microwave cavities energized by a RF power generator.  After leaving the accelerating 
structure, the electrons are deflected a net angle of 90° by an electromagnetic field (bending 
magnet) and subsequently stopped by a target of solid metal (typically tungsten) thereby 
suffering an energy loss through the emission of high energy bremsstrahlung and heat. The 
exit surface of this target is designated the source of radiation. The bremsstrahlung beam is 
formed by a flattening filter and a series of beam shaping devices, or collimators (Figure 3). 
The radiation is thereby converted into a photon beam of nearly homogenous fluence 
applicable for treatment. Alternatively, an electron beam can be created by replacing the 
tungsten target and flattening filter with a scattering foil. In this case beam shaping is usually 
achieved with the use of an electron tubus and cutouts of sufficient thickness made from a low 
melting point alloy. 
The gantry is mounted in such a manner that it rotates around the horizontal axis and 
so that the beam axis is kept orthogonal to this rotation axis. Further flexibility with respect to 
the incident direction of the beam is obtained by rotating the patient table. This allows for 
radiation to be delivered to the patient from nearly any direction. The intersection point of the 
gantry axis of rotation and the central axis of the beam is a fixed point in space denoted the 
isocentre. It is customary to define a right handed coordinate system – the isocentre system - 
with its origin at the isocentre. Consequently, the BEV perspective is realized by looking 
down at the isocentre from the beam source. 
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 The modern linac contains a multileaf collimator (MLC) that can be used to shape the 
photon beam to better conform to the target volume. The MLC can also be applied to 
modulate the photon intensity by sweeping the individual leaves across the beam. This 
technique constitutes the basis of intensity modulated radiotherapy (IMRT) – a radiotherapy 
technique that makes it possible to deliver highly conformal dose distributions.  IMRT is most 
commonly realized by either one of the following three methods: 
 
 The “sliding window” or dynamic multileaf collimator (DMLC) approach. For a fixed 
gantry position the opening formed by each pair of opposing MLC leaves is swept across 
the target volume under computer control, with the radiation beam on, to produce the 
desired fluency profiles [38].  
 The step-and-shoot, stop-and-shoot, or segmental multileaf collimator (SMLC) approach. 
For a fixed gantry position, a series of multilayer shapes (segments or subfields) is 
administered to create the fluency profile. The radiation is turned on only when the MLC 
leaves are stopped in each prescribed position [39].  
 Intensity-modulated arc therapy (IMAT, [40]) or volumetric-modulated arc therapy 
(VMAT, [41])  where radiation from one or more arcs (i.e. gantry rotations) are 
administered. Each arc constitutes a series of irregular apertures shaped by the MLC. In 
addition, the output fluence, the speed of rotation, as well as the MLC orientation may be 
varied as a function of the gantry angle.    
It must be noted that with the DMLC and SMLC approaches, several intensity modulated 
beams (typically 5 to 9) from different gantry angles are combined in order to create a high 
dose volume that conforms to the shape of the tumour.  
Clearly the MLC plays a vital role in modern radiotherapy; for beam shaping and even 
more importantly for modulation of the radiation intensity. It has been stated that “IMRT 
without a MLC is like a fish without a bicycle” [42]. It is of the prime importance that the 
mechanical precision and dosimetric characteristics of this device are maintained at all times 
to ensure correct dose to the patient. The impact of the latter aspect was addressed in Paper 
IV, and followed up by the detailed quality control study of the long term stability of MLCs 
from different vendors in Paper V. Lately, the significance of EPI and EPID technology has 
been demonstrated in facilitating real-time DMLC tracking of respiratory moving targets 
during delivery of arc therapy [43-44]. The concepts presented in Paper II for detection of 
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 single multi collimator leaves in an EPI, can very well be extended to verify that the actual 
tracking of the MLC is carried out correctly.     
1.7. Medical imaging in radiotherapy 
High-precision radiotherapy typically consists of five major phases: Patient scanning – 
treatment planning – set-up verification – beam-delivery – and response assessment. During 
all five phases imaging and image technology have always played important roles. A 
relentless development and innovations within this field have facilitated tremendous progress 
in the ability to discern tumour from normal tissue, and new image based techniques have 
been put into use to verify and even greatly improve treatment accuracy and precision. In so 
doing the collateral damage to normal tissue and the risk of treatment failures due to 
inadequate dose to the target have been reduced. In particular, the introduction of digital 
imaging techniques and new imaging modalities such as: CT, CT simulator, MRI / MRS, MR 
simulator, PET/CT, medical ultrasound (US) devices, optical surface scanners, Cone-beam 
CT (CBCT), EPI, and molecular imaging, have made possible great improvements in the 
quality of treatment planning, increased the precision of treatment execution, and augmented 
treatment response assessment.   
Dynamic imaging can be used to characterise anatomical motion (respiration, 
deformation). This technique has become increasingly more important in the radiotherapy 
process over the past few years. Likewise physiological properties (e.g. metabolic or 
functional activity) of the tumour before, during and after treatment can be assessed by 
dynamic studies such as 4D CT or PET and MR/MRS. The latter may sometimes be further 
supported by tumour biopsies and/or other invasive measurements of tumour characteristics. 
The aim is of course to make use of this information to enhance the geometric and dosimetric 
precision as well as the treatment efficacy, and to gain knowledge of tumour response. This in 
turn can be utilized to further optimize treatment quality.        
Three-dimensional medical images reflect different properties of the tissues and organs 
in the body.  The basic geometric unit is a volume element (voxel) that is specified by its 
dimensions in the x-, y-, and z-directions. These voxels are usually organized in a cuberille, 
and an image displays a cut-plane through this volume. The voxel values and images, 
respectively, may represent:  
 The linear X-ray attenuation coefficients (CT images). 
o The images exhibit a detailed view of the anatomy and form the basis for dose 
calculations and planning. 
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 o Pathology may show up as increased or decreased attenuation values, changes in 
morphology and/or enhanced uptake of contrast media.  
 The activity concentration of a radioactive compound (SPECT and PET images). 
o The images represent physiological processes in the tissues because the radioactive 
compounds enter biological pathways (e.g. uptake of radioactive glucose as part of 
the cell metabolism, or phosphonate compounds as building blocks of bone 
tissues). 
o Pathology may show up as increased or decreased uptake. 
 The magnetic resonance properties of the tissues or artificial contrast media (MR images). 
o The signal strength depends on the relaxation properties of protons in the tissues 
and the images provide excellent soft tissue contrast. 
o The images can provide measures of perfusion by the accumulation and clearance 
of contrast media. 
o In addition the images may provide a measure of proton diffusion coefficients. 
 The characteristics (resonance peaks) of the NMR spectrum (MRS, CSI) 
o Reflect the concentration of metabolites.  
o Pathology and aggressiveness may show up as changes in the ratio between such 
concentrations. 
 The magnitude of the reflected signals from longitudinal high frequency acoustic waves 
by the tissues (3D US images) 
o Doppler measurements of blood flow.  
 
Molecular imaging is an aggregated term including in vivo imaging of labelled biomolecules 
typically within the field of nuclear medicine including PET. Examples of the application of 
such molecules include:  
 Targeting angiogenesis (the formation of tumour blood vessels) using radioactive 
compounds that may bind to structures present in the recently formed new blood vessels.  
 The detection of sub-clinical tumour tissues by radioactive labelling of antibodies or 
receptor homing molecules and subsequent imaging of their concentration in the vicinity 
of the tumour.  
 Imaging of tumour proliferation with use of radioactive labelled amino acids (methionine, 
thyrosine), and imaging of hypoxia by quantifying the uptake of for example 64Cu-ATSM 
or 18F-MISO, respectively.   
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 The importance of the above mentioned development has brought about a number of 
new buzz-words to the field.  Image Guided Radiotherapy (IGRT) [27-28, 45] usually refers 
to image guidance techniques used at the time of treatment to guarantee that the CTV receives 
the prescribed dose, and/or that irradiation of critical structures is avoided. Some of the 
image-guided methods, portal imaging for instance, are more suitable for imaging rigid bone 
structures as encountered in the head and neck and pelvic regions. By exploiting the spatial 
localisation of the tumour with respect to these structures, an indirect verification of tumour 
position relative to the beams is achieved.  Other techniques, like US, X-ray fluoroscopy and 
possibly also CBCT, are able to localise soft tissue tumours and even determine non rigid 
setup variations and movements such as in the case of prostate and lung cancer [46-48]. 
Tumour surrogates like gold markers [49-50] have been introduced as a means to mitigate the 
lack of adequate soft tissue contrast in EPIs and CBCTs. 
Lately it has become common to broaden the scope of the term IGRT to encompass 
imaging for planning and treatment follow up as well. An example of the latter would be Dose 
Guided Radiotherapy (DGRT) that includes methods to retrospectively calculate the real dose 
distribution delivered to the patient in a treatment session. This dose can be obtained from 
EPIs where the image intensity is converted into transmitted dose to give portal dose images 
(PDIs) [20-26]. By back projection of these dose images onto a CBCT image volume acquired 
prior to the actual treatment session, the 3D dose distribution delivered to the target and to the 
organs at risk, at the time of treatment, can be estimated [51]. By comparing this single 
session dose distribution to that of the treatment plan, discrepancies in dose delivery can be 
detected and potentially mitigated (see below). Furthermore, a fraction by fraction record of 
the “true” dose accumulated in the tumour and normal structures can be established. 
The outcome of both IGRT and DGRT can be utilized to adapt the treatments to the 
measured daily variations in patient set-up, patient contour, the internal tumour position as 
well as tumour shape and size. New treatment plans can be created that compensate for the 
observed discrepancies for instance in dose delivery. In this manner uniformity in doses 
administered in a population of patients is enhanced. Eventually, such increased dose 
uniformity may improve the ability to measure and discriminate the effect of dosimetric and 
non-dosimetric factors on tumour and healthy tissue outcomes in clinical trials. By collecting 
IGRT/DGRT data from many patients, a more precise determination of treatment-specific 
tumour control and normal tissue complication probabilities, respectively, can be attained. 
This ongoing use of imaging to monitor, update and adjust the treatment is known as Image 
Guided Adaptive Radiotherapy (IGART) [52-54]. 
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 The ultimate goal is however to move from this population based knowledge to the 
application of individual patient-level biological information in order to design and carry out 
the optimal therapy for that individual. This type of personalized treatment strategy is called 
radiation theragnostics  [55] (from Greek therapeia: to treat and gnosis: knowledge). 
Theragnostic radiation therapy and imaging involves a process where the aim is to go from a 
usually uniform dose prescription (applicable to a group of apparently similar patients), to a 
voxel-directed prescription of a non-uniform 4D dose distribution based on functional or 
molecular image information that reflect the biological characteristics pertinent to 
radioresistance or radiosensitivity as outlined above. The latter approach is often described as 
dose painting by numbers and is seen to be designated the aggregated term Biologically 
Adapted Radiotherapy (BIOART) [56-58].    
 
1.8. Treatment volume delineation and visualisation in external beam radiotherapy 
The first aim of radiotherapy planning is to identify and differentiate cancer cells from normal 
tissue to produce a delineation of the Gross Tumour Volume (GTV). High sensitivity of the 
techniques involved in carrying out this task is paramount for a successful treatment outcome. 
As outlined previously, a number of sophisticated imaging techniques can be applied to 
facilitate this process.  Likewise, a high specificity is of importance to evade excessive side-
effects from irradiation of normal tissue.  
The resolution limit of modern 3D imaging is typically of the order 1 mm, and 
microscopic extensions of tumour cells below this limit are hard to discern clinically by 
imaging or other examinations. It is therefore customary to make use of a margin around the 
GTV in order to define a Clinical Target Volume (CTV) [12]. The magnitude of this margin 
will depend upon tumour characteristics and can vary depending on tumour-site and 
histology. Ultimately, advanced functional imaging systems correlated with image-registered 
pathological specimens will allow one to learn more about the true extent of the disease 
compared to the functional or physiological image; in particular to separate out normal tissue 
from disease at the tumour periphery and thereby reduce the uncertainty related to the sub-
clinical spread. When it is not possible to determine the CTV margin with reasonable 
accuracy, the margins must remain generous and conformal avoidance methodology could 
and should be deployed to spare critical normal structures.  
In addition, the accuracy and precision of external beam radiotherapy is deteriorated 
by inter- and intra-observer variations in the definitions of GTV/CTV, as well as an 
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 uncertainty in the position of the CTV with respect to the direction of the treatment beams 
during treatment [59]. The latter is inherent to the way in which radiotherapy is carried out, 
and is caused by internal organ motion that may displace the CTV relative to its planning 
position, alterations in the CTV shape, as well as day to day variations in the actual set-up of 
the patient. As a result, the margins are further expanded to encompass these inaccuracies to 
give the Planning Target Volume (PTV) [12], and a treatment plan conformed to the PTV 
must be created to ensure proper dose coverage of the CTV throughout the entire course of 
treatment. 
The above mentioned uncertainties and the margins needed to mitigate the effects, 
pose a problem as the irradiated volume inevitably will include healthy tissue. This unwanted 
side-effect should of course be minimized, but finding the optimal margins for the treatment 
of a particular patient in question is an intriguing challenge. Margins recipes based on the 
analysis of population based uncertainties have been presented [59-63], and in Paper VII this 
issue was investigated and a model to define the optimal CTV-PTV margin was presented. 
Despite tremendous advances in cancer care and within radiotherapy in particular, both 
technically and clinically, it is in many cases still challenging to achieve local cure or local 
tumour control. This anomaly may be summed up by the following statement (credited to the 
Canadian medical physicist Harold Johns):  “If you can’t see it, you can’t hit it, and if you 
can’t hit it, you can’t cure it.” The great achievements that have been made to the physical 
aspects of radiotherapy, i.e. the ability to accurately calculate and subsequently sculpt a 3D 
dose distribution inside the body has, as of yet, not necessarily been translated into improved 
cure rates even when these methods entail use of higher doses. This may be attributed to the 
fact that radiotherapy is still for a large part an evidence-based form of medicine. The detailed 
knowledge about the tumour’s response to radiation in individual patients, and the 
microbiological tumour characteristics that may affect this dose response, are still unknown or 
inaccessible to clinicians. We know that radiation works, particularly for a population of 
patients with a similar diagnosis, but not exactly why or how, and this shortcoming can 
evidently lead to occasional treatment failures.  Lately, the advent of molecular imaging and 
the conception of a biological target volume (BTV) [58] have gained footing as a viable 
notion for addressing the above mentioned contradiction.  
In this context imaging in the Beams Eye View holds promise to play an important 
role in order to shorten the gap between physical and biological realms of radiotherapy. The 
BEV has the potential to provide a detailed and intuitive (over)view, along the rays of 
radiation, of a very complex scene that contains a multitude of information objects, spanning 
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 from the anatomy and physiology of the tumour and surrounding healthy tissue, to radiation 
dose and tissue response; from a geometrical as well as a temporal point of view.   
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 2. Applications of digital imaging and image processing for the 
investigations and assurance of treatment precision: The evolving aims
 
The first set of aims for the present work was formulated as early as 1992. A common 
denominator has been the exploitation of digital imaging and image processing techniques to 
capture, create, and analyse information contained in BEV projections. Due to the rapid 
technological and scientific development in the fields of portal imaging, image processing and 
image communications, the aims were extended several times. However, the overall aim has 
always been to improve the precision in external beam radiotherapy. 
Many of the technical inventions that form the basis for the present work have been 
investigated a short time after they have been introduced into the market and thus reflect 
central aspects of the development in this field. The present dissertation is based on 
developments conducted by the author and the research papers published as part of this work. 
The main part of the software produced in the projects was written by the author.   
In parallel with the investigations, it has been an overall goal to continuously 
implement the ideas in the forms of applications that could be put into use in the busy clinical 
environments of the radiotherapy department. Additional efforts have been required to address 
and solve the real problems that inevitably emerge when such methods are used to analyze 
images of thousands of patients. 
This has necessitated the design and development of a comprehensive system that can 
provide efficient and reliant access to the vast amount of digital images produced for each 
patient, as well as to provide means to convey the results of the image analysis to the 
treatment personnel. As part of this strategy, new standards for digital image communication 
have been investigated, adapted and implemented to facilitate the desired work- and data- 
flow. 
  The aims of the BEV based development were to augment the planning sensitivity (i.e. 
the ability to adequately enclose the entire tumour in the high dose volume) and specificity 
(i.e. the ability to avoid normal tissue irradiation) when it comes to preventing real geometric 
and dosimetric misses during therapy. These aims and modes of operation hold the potential 
to improve local control and hence lead to better cure rates. 
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3. A comprehensive Beams Eye View based system for image workflow, 
processing and analysis for routine use in a large scale radiotherapy 
department: Development and implementations conducted by the author.
 
Image processing and analysis tools are often developed as part of an academic research 
effort. When these computer codes are to be used routinely in a large radiotherapy clinic, they 
must be embedded into computer programs suitable for running in a distributed environment 
available to the various groups of the radiotherapy staff. Ideally, these programs should be 
intimately linked with a system that can administer the huge amount of images and associated 
information created each day. On the other hand: the practical testing of such programs in 
such an environment will reveal errors and problems and thus spur further development of 
both the program codes, methodology,  and the supporting IT infrastructure. When 
successfully implemented, the new possibilities created will presumably lead to improved 
precision in the radiotherapy practice.  
This chapter sketches the historical development of BEV based image processing for  
patient set-up verification, image analysis of precision of equipment-dependant performances, 
and how these efforts were linked with the development that lead to the presented 
comprehensive system. The main aspects of this development were:  
 
 Method for fast generation of high quality of DRRs (Paper I) 
 Methods for image segmentation (Paper III) and registration [19]  
 Methods for detection of single MLC leaves in EPIs and the quality control of MLCs 
(Paper II, IV and V)  
 Comprehensive infra structure to support image and data workflow in the radiotherapy 
department [64-67] 
 Developments of systems for managing routine statistical evaluation of patient set-up 
errors and embedding the image analysis software in a record and verify system.  
 
The historical development is sketched as a background and as an instructive learning phase, 
but the solutions presented here are derived from work that was carried out over a period of 5-
7 years.   
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 3.1. Historical background and motivation for the presented development 
In the Norwegian Radium Hospital (NRH) the geometric accuracy of the patient set-up was 
historically addressed by a visual inspection and qualitative comparison of radiographic portal 
and simulator films, respectively. Typically, this was carried out by manually measuring the 
distance from the field borders, as depicted on the two films respectively, to bony structures. 
As a rule of thumb, discrepancies of the order 5 mm or less were considered acceptable. 
Evidently, this was an inaccurate approach because it was subjective and insensitive to more 
subtle deviations in the patient set-up.  In addition, the work-load and slow speed related to 
film development and handling of heavy film cassettes hampered extensive use of this modus 
operandi. Basically, this approach served as a “one-shot” verification and documentation of 
the treatment fields at the start of treatment, and may have prevented gross treatment errors or 
adverse events. It could not facilitate realization of the accuracy considered necessary in 
modern conformal radiotherapy of curative intent. Here a persistent set-up precision of the 
order of 1 mm (translations) and 1° (rotations) would be desirable to minimize the margins 
and adverse effects on healthy tissue.  
The advent of EPIDs and digital portal imaging provided new image processing 
abilities and spurred a development of computer-assisted techniques. Digital images lend 
themselves to frequent use of quantitative image analysis methods for the detection and 
subsequent correction of deviations in the patient position. Obviously, the accuracy of the 
analysis tools should match or even supersede the observed clinical distributions of random 
and systematic deviations in the patient set-up (see section 3.3).  
A project initiated at the Norwegian Radium Hospital in 1992 aimed to make image 
based verification an integrated part of the daily clinical routine in order to improve the 
accuracy and precision of radiotherapy. A part of this project was to investigate and develop 
techniques for automating the image registration process [19]. Initially this study addressed 
the comparison of digitized simulator and portal films. As the use of CT images for treatment 
planning and EPIDs became commonplace during the mid 90’s, these image modalities were 
replaced by the use of DRRs and EPIs, respectively, and these modalities became the focus of 
further research efforts in the project. DRRs rather than digital simulator images were 
considered to be the most reliable type of reference image since they were based on the actual 
treatment planning data. Early on in the project a demand emerged for DRRs other than those 
provided for by the planning system. A development commenced with the aim to provide a 
flexible program and user interface from which the user could specify different image quality 
measures depending on the final clinical use of the DRR. At an acceptable speed, high quality 
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 DRRs should be formed that could visualize soft tissue and bone, and in which different 
anatomical features could be distinguished. A first version of a DRR algorithm was completed 
by the author in 1996 and soon put into clinical use. Since then, the algorithm has been further 
improved and new functionalities have been added (paper I and section 3.10). 
3.2. Digital image communication and networking 
The access to efficient computer systems and networking architectures were considered 
necessary prerequisites for the realisation of optimal image based verification. Such 
technology is indispensable in order to fully exploit the vast amount of information offered to 
the oncologist by the various imaging modalities. In this context the network comprised the 
technological infrastructure needed to support a seamless connectivity and integration of 
radiotherapy equipment (e.g. imaging modalities, treatment units) and patient information 
systems (e.g. hospital information systems, electronic medical records, treatment planning 
systems, record and verify systems, Picture Archive and Communication Systems).   
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Figure 4 Illustration of the early server/client DICOM data- and work-flow solution developed as 
part of the NRH project. A query retrieve (Q/R) Service Class User facilitated search and transfer 
of DICOM data, and a storage service class provider / user (SCP/SCU) facilitated local storage 
as well as push/pull of these items to/from a local DICOM directory. A graphical user interface 
(GUI) made possible input of the basic search and retrieve elements such as patient ID, image 
acquisition date, and selection of which network application to interact with.    
 
The NRH project therefore also aimed to address data- and workflow related aspects of 
electronic portal imaging in order to promote and facilitate the integration of this new imaging 
modality into the clinical routine (Figure 4) [64-67]. This involved the establishment of a long 
term strategy for exploiting and implementing new standards for digital image communication 
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 and archiving in medicine (e.g. DICOM and PACS). Alongside these initiatives, a 
development of custom made interfaces to extract images from vendor specific image 
databases were considered necessary as intermediate solutions.  
The clinical use of standards for networking and image communication has in recent 
years been addressed by the IHE-RO initiative (Integrating the Healthcare Enterprise – in 
Radiation Oncology) endorsed by several professional organisations in the field [68]. The 
various IHE-RO committees unanimously promote the application of existing standards for 
data communication and storage (e.g. HL7, DICOM) when it comes to the development and 
implementation of new solutions. Within this context, various IHE-RO working groups have 
outlined a number of clinically relevant use cases (workitems) that demonstrate desired 
workflows (profiles) and corresponding inter-operability that vendors should adhere to when 
releasing new products. A vendor commitment to IHE-RO defined protocols would hence 
smooth the integration of devices from different manufacturers in a multi-vendor 
environment.  
A suite of computer programs were developed as part of the NRH project. An 
important design aspect was to maintain a modular programming code that readily could be 
adapted to different system architectures, operating systems and computer environments as 
well as to comply with the IHE-RO recommendations. A high level programming language 
was used to allow for easy integration of the programs with existing clinical computer 
systems. This facilitated a fairly trouble-free transition from a dedicated system running in-
house, to a suite of programs that later on was embedded into a commercial radiotherapy 
record and verify (R&V) system [69].  
3.3. Selection of methods for the first radiotherapy image registration efforts in the 
Norwegian Radium Hospital 
A discrepancy between the intended (DRR) and measured (EPI) position of anatomical 
structures relative to the field border – attained by comparing these BEV images - is 
considered a set-up error. It is customary to assume that the origin of this error is an 
unintended translation and/or rotation of the patient pose relative to the direction of the beam 
(i.e. machine coordinate system). The fundamental challenge in this context is to deduce this 
translation and/or rotation from the measurements in the BEV, and furthermore to estimate a 
shift and/or rotation of the patient support system to mitigate the incorrect set-up and thereby 
maintain the planned treatment accuracy. An alternative approach would be to redesign the 
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 treatment plan to account for the altered pose, but for a number of technical reasons this has 
not been a viable option until recently [70-71].  
A critical prerequisite in this context is to know the relationship between the geometry 
of the BEV images and the patient support system, and furthermore to transform the BEV 
images into one common coordinate system in order to facilitate a comparison of image 
intensity patterns in the two images (a process commonly denoted image registration). 
Likewise, image similarity measures must be established and applied to quantify the degree of 
correspondence in the set-ups as depicted in the DRR and EPI, respectively. Several 
intermediate steps are usually carried out as part of this process, and different approaches and 
methods (presented below) have been developed in the NRH project to resolve these issues. 
3.3.1. Field shape matching to establish a transformation into one common coordinate 
system
In theory, an accurate quantification of the location and orientations of the EPID with respect 
to the treatment table (or patient) would make possible a direct conversion of the measures 
derived from the EPI into a corrective table shift. This would require an absolute and minute 
calibration of the position of the EPID relative to the isocentre. However, most EPID 
attachments, especially those that were available in the early days of the EPI era, are made 
subject to sag, wear and tear in the suspension. The effects of such abrasions may jeopardise 
the precision of this procedure.  
An alternative and more flexible approach that is independent of the EPID position 
was selected for the NRH project. This method involved matching the location and orientation 
of the collimators, depicted as the field edge in the portal images and as the field border in the 
reference image (e.g. DRR or simulator image), respectively. The field border, representing 
the planned outline of the beam, was constructed from a combination of the positions of the 
field shaping devices defined in the plan prescription. The aims of this field shape matching 
are two-fold: First to verify the shape of the treatment field, and secondly, to establish the 
geometric transformation (magnification, translation, and rotation) between the EPID and the 
reference image coordinate systems, respectively. The relationship between the coordinate 
system of the reference image and the patient support system can usually be established from 
the treatment plan. This implies that by application of the derived transformation, a set-up 
discrepancy detected in the EPI can be translated into table shift values. 
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Since this procedure involves the use of the field edge of the EPI, a robust and fast 
method for field edge detection was developed taking into account the response characteristics 
of different EPIDs. Initially edge detection was carried out applying an implementation of the 
Mexican hat or generalized Laplacian operator [72] (Figure 5, upper row). This is a rotational 
invariant operator where noise suppression and edge detection can be achieved with the use of 
one convolution kernel only. The zero-crossings of this operator response in the beam  
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Figure 5 The panel displays portal image field edge detection. Upper row illustrates the use of a Mexican hat operator 
(A) that is convolved with the EPI (B). The resulting zero responses of the convolution in the beam penumbra (C) are 
chained together to create a polygon that represents the field edge (D). The lower row illustrates the Canny edge 
detector approach: The Sobel operators (A) are convolved with a noise suppressed EPI (B) to give the gradient 
magnitude image (G). A search for a local maximum in the gradient magnitude, in the gradient direction (non-maximum 
suppression), is then carried out to locate the field-edge position. In the resulting binary image, the coordinates of the 
local maxima are chained together to create the polygon that represents the field edge (H). 
 
penumbra were found to correspond very well with location of the dosimetric field edge. 
However, the lack of information of gradient direction with this method would sometimes 
lead to loops (false edges) when trying to chain the zero-crossings into a continuous field edge 
outline. Therefore, a method based on the Canny edge detector was implemented and replaced 
the Mexican hat scheme [73] (Figure 5, lower row). The EPI is first convolved with a 
Gaussian filter to reduce noise. Then the image intensity gradients in the horizontal and 
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 vertical image directions are approximated by a convolution with Sobel operators. The 
horizontal and vertical responses are combined into a gradient magnitude image as well as 
into an image holding the gradient direction. Only if the gradient magnitude assumes a local 
maximum in the gradient direction, the corresponding image pixel is defined to be on the field 
edge (non-maximum suppression).  
 The field shape matching was carried out applying a chamfer matching technique [74]. 
More specifically, a polygon that represented the field border was superimposed on a distance 
map created from a binary image that represented the field edge (Figure 6). The root mean 
square average (r.m.s.) of the pixel values in the distance image that coincided with the 
polygon, was used as the measure of correspondence. The search for the set of geometrical 
transformation parameters that minimized the r.m.s. was carried out using a simplex downhill 
technique [75].    
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Figure 6 The geometric transformation (i.e. translations, rotation and magnification) between the coordinate 
systems of the reference image (panel A) and portal image (panel B), respectively, is found applying a chamfer 
matching technique: The polygon representing the field border in the reference image (red outline) is superimposed 
on the Euclidean distance map of a binary image representing the field edge (indicated by the white outline in panel 
C). The root mean square average (r.m.s.) of the pixel values in the distance map that coincide with the red outline, 
is used as a measure of geometric fit. Panel D illustrates this concept. A simplex downhill technique is used to 
minimize the r.m.s. value (panel E). The geometric transformation that minimizes the r.m.s. is defined as the 
position of the best fit (panel F). 
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Evidently, field shape matching as such is an intermediate step. The program was therefore 
implemented with no need for user interactions, but allowed for a visual inspection of the end 
result. In hindsight, the method has proven to be very fast and reliable and only a few minor 
changes have later been introduced. 
3.3.2. Image segmentation, registration and fusion 
The geometric transformation that came out of the field shape matching was used to put the 
DRR and EPI into one common geometrical frame of reference. Further image registration 
based upon a direct application of image-intensity techniques, was made difficult by the 
inherent differences in the physical aspects of the image formation including differences in 
EPID technology: DRRs were created with high tissue contrast and in such a manner that 
anatomical landmarks could easily be discerned and extracted. Electronic portal images on the 
other hand usually have a low tissue contrast because of the high energy of the X-rays 
(typically 4-25 MV) that are used for creating the images (compare for instance panel A and B 
in Figure 6). The latter can make it hard to visually distinguish the anatomical structures or 
fiducial landmarks in the EPIs that are relevant to the set-up verification process, and the 
comparison of the EPI with the DRR can be error prone and time consuming.  
An important goal of the NRH project was therefore to develop computer assisted EPI 
contrast enhancement and segmentation techniques as a desirable pre-processing step to 
facilitate the image registration. The ultimate aim was to reduce the need for user interaction 
to a minimum (i.e. make the process less subjective) and thereby improve the accuracy and 
precision of the registration result.   
The aim of image segmentation in general is to subdivide an image into constituent 
parts or objects that display similar characteristics. Typically this implies the identification of 
image regions of pixels that adhere to some predefined statistical or morphological patterns 
defined globally and/or locally. The extracted Regions of Interests (ROIs) are usually 
identified either by a description of the boundary that encloses the region, or by the image 
coordinates of the pixels that belong to the ROI.      
In this context the goal was to extract homologous features from the two images (e.g. 
DRR and EPI), and subsequently to devise a distance measure that could be used to estimate 
the degree of mismatch between these features. The coordinate transformation that minimizes 
(or maximizes) this distance is then applied to evaluate the correctness of the patient set-up. 
The parameters used to model the coordinate transformation between the two datasets depend 
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 on the modalities involved and the clinical site. In the simplest situation, it is only necessary 
to account for differences in patient orientation (pose) at the time of imaging. For rigid 
anatomy, such as the skull and pelvis, only three rotation angles (x,y,z) and three 
translations (tx,ty,tz) are usually needed to describe any deviations in the pose. The presence of 
image distortions or mis-calibrated imaging devices would require more degrees of freedom 
such as anisotropic scaling (sx,sy,sz). However, this really is a quality control issue of the 
EPID, and it is customary to assume that such effects are corrected for prior to image 
registration. Evidently, the situation becomes more difficult when the anatomy involved is not 
rigid (i.e. deformable). In such cases a more complex spatially and temporally variant 
transformation involving a larger number of degrees of freedom is required to register the data 
properly. The latter type of registration of medical images is a very active area of 
investigation. Elastic registration methods based upon for instances measures of entropy have 
been implemented in clinical applications [76-77]. In the case of the 2D images considered 
here, only the rotation angles x and z can be measured and was included into the metric.  
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Figure 7 Illustration of different image segmentation techniques: 
Panel A shows original EPI. Panel B shows a binarised version A 
after unsharp masking. Panel C shows the original EPI. Panel D 
shows a binarised version of C after local adaptive thresholding 
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 Initially it was, however, decided to only consider rigid transformations and to disregard 
rotations. The latter was motivated by the fact that only translational discrepancies could 
easily be corrected for clinically by applying couch shifts. 
A number of techniques for image enhancement and automated feature extraction were 
implemented and tested as part of the NRH project development [4, 19]. The outcome of the 
techniques developed can be categorised into three classes of increasing data complexity: 
point features, curve features, and template features. Examples of point features are manually 
placed fiducials, projections that represent recognizable points in bone anatomy, or 
(implanted) radio-opaque markers (e.g. gold markers in the prostate). Examples of curve
features are edges (surfaces) or ridges in the projection of bony anatomy, grey value medial 
axes, or simply the projected contours of the radiation field edge. Examples of template 
features are regions of pixel values that contain one or more projections of anatomical fiducial 
structures. Template features provide more information for image alignment than point or 
curve features and may consequently be applicable to a larger range of treatment sites.   
In the NRH project templates created from the high intensity ridges formed behind the 
crests of bones were chosen as the most appropriate image features since these are present in 
both EPIs and DRRs. Curve and point features were thus inherently supported. An unsharp 
masking technique  (Figure 7, panel B), the use of a gradient operator and global thresholding 
and subsequent thinning were used to extract the ridges from the images [19]. Later on a local 
adaptive binarization (Paper III) was introduced as a simpler, faster, and more robust 
procedure (Figure 7, panel D). This preprocessing allowed for an implementation of both 
semi-automated and fully automated template based matching. 
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Figure 8 Illustration of cross correlation to establish the translation between the two templates of the DRR and 
EPI, respectively. Panel A: Before correlation. Panel B: Illustrates the correlation function where the position 
of the peak value is used as a measure of displacement. Panel C: After applying the translation values 
corresponding to the position of the cross correlation peak. 
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 In the NRH project this was initially achieved applying a cross-correlation approach 
[19] (Figure 8) and later improved by a method based on chamfer matching. The latter is 
illustrated in Figure 9 demonstrating the sequence of operations involved: Extraction of a 
structure template from the DRR (panel A), the transferral of this template to the EPI applying 
the field shape matching transformation matrix (panel B), and finally the establishment of the 
geometric set-up deviation using chamfer matching (panel C). In this case a binarised version 
of the EPI was fit to the distance transform of the structure template of the DRR. The latter 
panel shows a superposition of the match results based on 25 image registrations.  
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Figure 9 Illustration of automated DRR-EPI registration for quantification of patient setup deviation: 
A. DRR with anatomical landmarks. B. Corresponding EPI with extracted structures (red) and the 
landmarks transferred from the DRR superimposed (green). C. Distance transform of the structures in 
A superimposed with the matched position of the structures from B after chamfer matching. D. The 
position(s) of the treatment beam based on the measured the set-up deviations of 25 consecutive 
treatment sessions.       
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 3.4. The first system: RTNavigator; design and workflow considerations 
The system that was developed, the RTNavigator, was planned and implemented to include 
the methods outlined above. The designed workflow comprised the following sequence of 
operations:  
 
1. Import of treatment planning data and corresponding images; either by the use of an in-
house developed DICOM query and retrieve and/or storage service class provider program 
package (Figure 4), or by proprietary data mining of vendor specific databases utilizing 
Open Database Connectivity (ODBC) application programming interfaces (API). 
2. Automatic detection of the field edge in the portal image and field outline in the simulator 
image, respectively. 
3. Automatic extraction of anatomical fiducials in the portal and simulator images, 
respectively. 
4. Matching of the field shapes in order to establish the geometric transformation (i.e. 
magnification, location, and orientation) between the EPID and isocentre coordinate 
systems, respectively, providing a transform matrix.   
5. Use of the transform matrix to position the fiducials from the simulator image correctly in 
the portal image with respect to the portal image field edge.  
6. Application of cross correlation to match the location and orientation of these fiducials in 
order to disclose possible rotation and/or translation of the patient set-up. This operation 
results in a quantification of the patient set-up deviation (in the coordinate system of the 
EPID).   
7. Use of the transform matrix to convert the deviations into isocentre coordinate system 
units (millimetres). 
8. When possible combine set-up deviations from orthogonal beams to compute the lateral, 
longitudinal and vertical table shifts that are required to correct the observed set-up errors.   
9. Systematic storage of measured set-up deviations and image registration data.      
 
It was decided to present set-up errors on-line in the patient support coordinate system 
whenever possible, to facilitate corrective actions, i.e. translations and/or rotations of the 
treatment couch. The latter was carried out manually by the staff at the treatment unit.  
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 3.5. Clinical experience and further development of the RTNavigator  
The demonstrated usefulness of the RTNavigator programs and the associated image analysis 
methods motivated further steps to be taken in order to implement their use into the clinical 
routine. In parallel with the in-house developments, advances in treatment delivery techniques 
(e.g. IMRT) along with an increased scientific activity on the international scene exploring the 
use of EPIDs in other domains such as dosimetry, encouraged us to continue the development. 
In addition, feedback from users and conference discussion contributed significantly to new 
ideas and improvements in the design of the system. These fruitful discussions and clinical 
experience gave rise to the following RTNavigator enhancements:  
 
 The precision of the field shape matching was improved by extensive dosimetric 
characterisation of the EPID response and development of an algorithm for precise 
detection of the corresponding field edge.   
 The precise positions of the individual leaf tips and flanks of the MLC were detected by a 
tailored EPI processing technique developed for that purpose (Paper II).   
 A database system for long term storage of images and deviation data resulting from each 
treatment session was designed and implemented, intimately linked to the R&V system. 
 The deviation data stored in the database were used for longitudinal follow up, and an 
analytic tool was developed to discriminate between random and systematic set-up 
deviations from sliding average calculations.  
 From a combination of detected set-up deviations derived from the acquisition of 
orthogonal EPIs, the required corrective table top translations were calculated.  
 The demand for robust and reliant automatic matching spurred actions to further 
sophisticate the pre-processing of the images involved. This processing comprised of 
image segmentation (binarization), ridge detection and adaptive histogram equalisation 
(Paper III).  
 In treatments where the field extended outside of the EPID, a routine was developed to 
clip the planned field outline to comply with the edge of the EPID. By this technique 
erroneous field shape mismatches were avoided. 
 
 
 
 31
 A few remaining issues or weaknesses were identified, and there were no reliable solutions 
developed within this project to resolve these. The most important ones were:  
 The DRR/EPI matching technique, even with combined use of orthogonal EPIs, did not 
enable the detection of rotations around the patient’s lateral and longitudinal axes, 
respectively. This was caused by a geometric degeneracy intrinsic to the method and can 
lead to incorrect set-up error measures as rotations can be misinterpreted as translations. 
 The automatic extraction of ridges in the EPI and/or subsequent template matching on 
occasions displayed unacceptable high failure rates primarily caused by very low contrast 
detail in the EPI. As a consequence, the outcome of the template matching would require 
user verification on a regular basis.   
 Field size errors (not field shape errors!) could not easily be detected because any 
difference in magnification between the EPID and isocentre coordinate systems was 
determined intrinsically in the field shape matching procedure. 
3.6. The second system version: Image Based Verification - IBV 
During the early days of the RTNavigator development and the introduction of EPIs in 
radiotherapy, we experienced a lack of an adequate infrastructure to manage image 
registration results and a longitudinal monitoring and handling of systematic and random 
deviations. This made it difficult to fully exploit the new possibilities provided by EPI and to 
implement efficient measures in daily routine to reduce the impact of set-up errors. The 
apparent answer to this issue was to intimately integrate the RTNavigator with the hospital 
radiotherapy Record and Verification (R&V) system (VISIR, Nucletron BV). The R&V 
system is the sole source of planning/set-up data during treatment execution and provided an 
appealing framework for conveying corrective actions derived from the EPI analysis. In 
cooperation with Nucletron BV a commercial version of the RTNavigator was implemented 
and designated the acronym IBV (Image Based Verification). The IBV module, made ready 
for sale in 2003, supported the following functionality: 
 
 Scheduling of portal image acquisition according to predefined protocols, and subsequent 
image retrieval and automatic import of acquired images using DICOM.  
 Scheduling of image based patient set-up verification and approval according to various 
action level strategies.  
 Semi-automatic 2D image registration applying template matching - including a workflow 
manager to guide and visualise the intermediate steps of the image registration process 
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 (e.g. preparation of the reference image, portal image field edge detection, field edge 
match, anatomy match and the presentation of the results).  
 Trend analysis of image registration results including techniques for combining the match 
results from the analysis of multiple fields at different gantry angles.    
 Scheduling of patient reposition requests (i.e. table movement) based on the outcome of 
the trend analysis, either by prescribing new relative table coordinates (fully automatic 
procedure), or by a translation of patient skin marks (manual procedure). 
 
By December 2011, the IBV was in daily clinical use on 6 treatment machines at the 
Norwegian Radium Hospital. On average roughly 100 pairs of images have been registered 
for set-up analysis every day for the past 8 years amounting to more than 200 000 image 
based set-up verification procedures handled by the system.  
3.7. Imaging, set-up correction strategies, and trend analysis
The potentially ample access to meticulous measurements of patient set-up deviations made 
possible by EPI, created a need to consider and conceive cost efficient imaging and set-up 
correction strategies. It is common to describe set-up deviations as the combination of a 
systematic and random quantity. The systematic component represents the recurring 
difference between the intended and actual set-up, whereas the random component represents 
the fluctuation in the set-up deviations that is typically observed during each session. The total 
set-up deviation is therefore the sum of the systematic and session specific component and 
gives rise to a frequency distribution of set-up deviations over all sessions. The systematic set-
up deviation is characterised by the average value of this distribution whereas the random 
component is often characterised by the corresponding standard deviation.  
In this context, the concepts of off-line and on-line verification protocols have been 
introduced to deal with the measured set-up deviations [78-79]. In the case of an on-line 
protocol images are acquired at the beginning of each treatment session applying just a minor 
(negligible) part of the fraction dose. While the patient is awaiting treatment completion, the 
image analysis takes place. An on-line correction protocol will thus reduce the impact of both 
systematic and random set-up deviations. Evidently, this is a time critical process as a proper 
corrective action (e.g. shift of the treatment table top) must be established and take place as 
soon as possible after image acquisition. Otherwise inevitable random disturbances in the 
patient pose or target volume position will undermine the benefit of the procedure. In 
addition, this method is work-load intensive and costly as patient throughput is lowered.  
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 With an off-line correction protocol, images acquired during treatment are analysed 
after the completion of a treatment sessions, and a sliding average is calculated from the 
measured deviations. The intention of this approach is to attain an estimate for the systematic 
component and apply this estimate during subsequent sessions, thereby neglecting the impact 
of the random component. Statistically, the power to extract the systematic from the random 
component increases with the number of image acquisitions (at different sessions). This may 
seem a paradox considering the clinical desire to reveal and mitigate the systematic set-up 
errors as soon as possible after treatment start. Off-line protocols will include an increasing 
number of images and related analysis results as the treatment progresses. These should be 
considered in conjunction in order to deduce reliable measures of corrective action based on 
statistical evaluation of the image registration results. The latter aspect represents a logistical 
challenge in which workload and expediency must be balanced against imaging frequency. 
In the IBV system this issue was addressed by facilitating the use of two different 
action level strategies published in the literature. The Shrinking Action Level (SAL) [78] and 
extended No Action Level (NAL, eNAL) [79-80] protocols provided the necessary tools to 
unveil systematic set-up errors by the utilisation of frequent imaging (analysis) early in the 
course of treatment followed by (typically) weekly imaging.   
In the SAL protocol a predefined threshold value that scales with the inverse square 
root of the number of measurements, is used to determine whether a given set-up deviation is 
to be corrected, i.e. to distinguish a random from a systematic set-up error. This threshold 
value can be obtained from a retrospective study of the set-up precision of a patient 
population that undergoes a site specific treatment regiment.  
In the eNAL protocol a correction obtained from the average set-up discrepancy is 
executed when a predefined number of measurements (typically 3) have been acquired, and is 
subsequently followed by (typically) weekly measurements.   
The efficacy of the SAL approach was evaluated as part of this project using the 
RTNavigator program for a group of patients that were treated for cervical cancer. These 
patients were treated with two opposed beams and for the AP field and EPIs were acquired 
using the PortalVision system (Varian Inc, Palo Alto, USA). First one group of 30 patients 
where followed up by an imaging schedule that was standard clinical practice of that time, i.e. 
one portal image at the first treatment session. A correction was introduced if a deviation 
larger than 5 mm was discovered. In order to establish an estimate of the threshold needed for 
the use of the SAL protocol, EPIs were acquired on the next three sessions as well, but no 
correction action was taken. For a second group of 30 patients, images were acquired at the  
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Figure 10 The figure illustrates the efficacy of the SAL protocol when applied to the AP field of a group of 
cervix cancer patients (30 patients in each group). Panel A shows the systematic set-up deviations measured 
in the lateral and longitudinal directions without the use of SAL, and panel B shows the corresponding values 
with the use of SAL. The systematic deviations in the lateral and longitudinal directions decreased from 1.9 to 
1.1 mm, and from 2.4 to 1.8 mm, respectively, with the use of the SAL protocol. The red ovals encompass 95% 
of the systematic set-up deviations. Panel C shows the fraction of patients (in %) that had a systematic set-up 
deviation above a given value (abscissa) - here given as the length of the systematic 2-dimentional 
displacement from isocentre (in mm).  The red curve shows the results with and the blue curve without the use 
of the SAL protocol, respectively.
first four treatment sessions and corrective action was taken if a deviation greater than the 
relevant action level was observed. An initial action level of 6 mm was used (around 3 times 
the standard deviations of all set-up deviations found for the first group of 30 patients). The 
results demonstrated (Figure 10) that the use of SAL gave a reduction in the systematic 
deviations (defined as the standard deviation of the average of the average deviations for each 
of the 30 patients).  In Figure 10 one can clearly see that the average of the set-up deviations 
in the lateral direction was not zero. In fact it was -1.0±0.4 mm (95% CL), i.e. significantly 
different from zero. The underlying cause of this anomaly may have been a misalignment of 
the light and the radiation fields, respectively, of the particular treatment machine that was 
used to treat the patients studied.  
Evidently, the concept of an off-line correction strategy collapses if the random 
component is a major contributor to the set-up deviations. In this case only on-line imaging 
will suffice. The choice of correction strategy may typically be a compromise from balancing 
of work-load related issues (image acquisition and analysis and treatment machine 
occupancy) and the potential clinical benefit or demands on the precision in relationship to the 
safety margins in use.   
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 3.8. Imaging dose in the Beams Eye View: EPID based absolute dosimetry 
The accuracy of external beam radiotherapy may be characterised by two measures: The 
geometric precision in the patient set-up and beam-limiting devices with respect to the 
tumour, and the dosimetric precision in delivered dose to the tumour. Obviously the geometric 
set-up precision (set-up errors) will constitute a bearing on the dosimetric accuracy, but day-
to-day variations in for instance patient anatomy can have an independent impact on the latter.    
The idea of converting the electronic portal imager signal into a measure of radiation 
dose (or dose rate) came about more than two decades ago [81]. To achieve this, the EPID 
must be operated in an integrating mode to capture the radiation transmitted during the entire 
exposure of each beam. In addition a number of different (non-imaging related) EPID specific 
characteristics must be established in order to attain a measure of dose within a precision of 1-
2% (1 SD). Having this established, the resulting Portal Dose Image (PDI) is thus another 
example of applying the BEV geometry for treatment verification. 
The NRH project was extended around 1999 to also include preliminary investigations 
on the use of EPIDs for dosimetric purposes. In the first phase the dose response 
characteristics of the PortalVision LC250 detector from Varian was studied in order to make 
possible a transformation of the EPI signal into dose per monitor unit [82]. This work 
included among other aspects: measurements of detector dose rate dependency, field size 
dependency, influence of detector cross-talk from lateral scatter inside the detector housing, 
influence of patient scattered radiation on detector response, individual detector element 
sensitivity, build-up requirements, and long term stability (Figure 11).  
In the next phase, a previously developed formalism [83] was elaborated that enabled 
the calculation of dose to a water equivalent phantom located in the position of the EPID to a 
depth equivalent to the thickness of the EPID. The aim of the calculation was thus to facilitate 
a prediction of the portal dose transmitted to the EPID behind the patient, i.e. to create a 
Predicted Portal Dose Image (PPDI). The work in this study comprised extensive testing of 
the validity of the formalism and the model for transforming EPI signal into PDIs – the PDI 
representing the dose per monitor unit - as well as the testing of a concept based on a gamma 
analysis [84] for the comparison of PDIs and PDDIs.  A dedicated module was implemented 
and made part of the RTNavigator to allow for a conversion of EPIs into PDIs, and to report 
the distance to agreement (DTA), the dose difference (DD), and the combination of these to 
form the a common measure – the gamma index – in order to facilitate a comparison of the 
PPDI with the corresponding PDI. The latter would represent a sophisticated method to verify 
 36 
 correct dose delivery and patient set-up. The results of this work are reported in Paper VI of 
the present thesis. 
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Figure 11. Illustration of various dose response characteristics established for the Varian LC250 EPID: 
Panel A shows the EPID dose rate response for a 6MV beam. Panel B shows the EPID field size dependency 
for a 6MV beam. Panel C shows EPID long term stability for a 4 MV beam. Panel D shows a comparison of 
a dose profile of a PDI (solid line) and the corresponding profile measured with an ion chamber located 
inside a mini phantom (dotted line).
 
Recently, methods have been developed to back project the PDI into the patient 
anatomy applying either CBCT images or the planning CT images, and compare the resulting 
dose distribution with the planned [51, 85]. Further investigations into this area were beyond 
the scope of the present thesis.  
3.9. Imaging in the Beams Eye View for quality control of the Multi Leaf Collimator  
The electromechanical aspects as well as the clinical use of the MLC have rapidly evolved 
since the early 90’s when the MLC was given a commercially acceptable design and became 
readily available [86-87]. In modern radiotherapy the multi-leaf collimator of the linear 
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 accelerator has become instrumental to the formation of the sophisticated dose distributions 
by for instance arc IMRT  [88]. The first treatment machine equipped with a MLC was put 
into clinical use at NRH late 1992 (one of the first of its kind world wide).  
The BEV provides an intuitive basis for investigating the MLC performance since the 
principal path of operation of the MLC is orthogonal with respect to the central axis. The 
overall shaping of the radiation field, the accuracy and precision of speed and location of the 
individual leaves can be studied utilizing this viewing geometry. This also applies to the 
dosimetric properties. As a part of the NRH project development of methods to detect and 
monitor the position(s) of the collimator leaves was initiated around 1995 exploiting the new 
possibilities provide by EPIDs. The results of this early work are outlined in Paper II. The 
methods developed for a dosimetric correct detection of the field edge from the electronic 
portal images and determination of each single leaf position, were included in the 
RTNavigator software and also made part of the commercial IBV release.  
By 2005 the MLC had become the standard field shaping device on the majority of 
treatment machines in the department, and IMRT was being introduced as the preferred 
treatment technique for patients receiving radiotherapy for cancer in the head and neck region. 
The MLC systems were subject to a mechanical quality assurance program that included a 
meticulous calibration of the individual leaf positions. However, this procedure contained 
elements of visual assessment by the staff at the treatment unit that could induce systematic 
errors of the order 1-2 millimeters. Such errors could potentially have an impact on the 
delivered dose distributions for treatment techniques that contained a large number of smaller 
treatment fields, such as the IMRT plans that started to emerge in the clinic. A study was 
therefore initiated to investigate the consequences of such errors. Radiographic films were 
exposed in the BEV perspective to investigate the sensitivity of systematic leaf calibration 
errors on the delivered dose distributions. The films were subsequently digitized using the 
scanner software developed in the early years of the NRH project, and the gamma analysis 
software of the RTNavigator used to analyse the results. The findings are presented in paper 
IV.   
The principal ideas and learning experiences of the works of paper II and IV initiated a 
need to investigate the reproducibility and long term stability of the MLCs from the three 
vendors of linacs installed in the hospital. The results of this work are described in paper V, 
and the concepts and software that were developed to analyse stripe test images presented in 
that work are still in use in the clinic.   
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 3.10. Extended development and use of the DRR algorithm 
A full projection DRR represents a condensation of the 3D anatomical information and 
inherently some important features may be obscured by the overlaying structures. The 
properties of the DRR should be adapted to its intended use. A DRR should clearly depict 
bony landmarks and fiducials implanted to facilitate patient set-up verification and avoid other 
structures that can disturb an automated image registration procedure. Furthermore, for the 
DRR to be used as a means to ensure sufficient coverage – and avoidance of critical organs - 
both the tumour and all critical organs should be displayed. This also means that information 
from other kinds of images (MRI, PET/SPECT) should be visualized. The above requirements 
were the background for the extensions of the DRR functionalities presented in Paper I. 
DRRs originating from different modalities can be formed and displayed by image 
fusion and visualization techniques using a geometry that lets the central ray (or central axis 
of projection) always pass through the isocentre of the treatment plan. Through the intimate 
integration of the RTNavigator - and later on IBV - with the R&V system, this detailed set-up 
information was made readily available to the DRR program that was developed. The 
treatment field outline together with the position of the central ray constituted both a visual 
and a physical frame of reference for the BEV/DRR display. Depending on the context, these 
custom made DRRs were shown either side by side or with several types of image 
information superimposed in one display. 
Prior to or during the projection that forms the DRR, it is possible to manipulate the 3D 
image information in the following general ways: 
 Preprocessing of the 3D image volume to enhance the visibility of certain structures or 
tissue classes of interest. This can be carried out in a number of ways e.g. by the use of 
different transfer functions or intensity mappings. 
 Segmentation of organs of interest such as bone, kidneys, heart, liver, intestines, tumour, 
or by the use the image subtraction techniques such as subtract pre-contrast image from a 
contrast image [89]. Segmentation may also include the use of volumes of interest 
imported from the treatment planning system.   
 Limitation of the range of the image volume that is projected. The purpose is to remove 
the disturbing effect of overlaying (over-projected) tissues. Typically the range can be 
defined to include only the tissues in the volume surrounding the tumour. 
 Formation of maximum intensity projections (MIP) e.g. to check that all the tissues that 
have accumulated 18F-FDG have been included in the treatment field.   
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The present version of the DRR algorithm can without modification be used for all the 
purposes described above, and the technical details of the implementation is described in 
paper I. Since the programs were written in a 4 generation language, additional modifications 
are feasible when required. In Figure 12 a few examples of the use of these new 
functionalities of the DRR formation are illustrated. As frames of reference and to facilitate 
visual comparison the following overlays may be included:  
 the location of the beam limiting devices and central axis,  
 segmented gold markers, and  
 segmented organs (lung, urinary bladder etc) or tumours. 
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Figure 12 Illustration of the visualisation possibilities of the extended version of the DRR algorithm: Panel 
A-C displays three different beams eye view projection of the CT images of a patient that was given 
stereotactic radiotherapy to a tumour in the lung. Panel A shows a bone enhanced DRR. Panel B shows a 
combined range limited bone and lung/soft tissue enhanced DRR. Panel C shows a range limited tumour 
enhanced DRR clearly visualising the position of the tumour. Panel D-F illustrates different visualisations of 
gold markers implanted in the prostate of a patient treated for prostate cancer. Panel D shows the frontal 
view of a bone and implanted gold marker enhanced DRR superimposed on an enhancement of the soft 
tissue of the GTV. Panel E shows a lateral view of a range limited DRR (avoiding the most lateral parts of 
the pelvis and the left and right femoral head) where the locations of the automatically detected gold 
markers are indicated. Panel F shows a lateral view of a range limited DRR superimposed on the BEV 
projection of the outlined CTV (red), rectum (blue) and bladder (green).
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 3.10.1. Imaging the Beams Eye View in combined CT and MRI based radiotherapy 
planning
MR images could provide reference images equivalent to the CT based DRRs. In such cases, 
the use of CT based simulation could be omitted [29, 31, 90].  An intermediate approach is 
first to coregister the MR images with the planning CT images. The registered MR image 
volume is then used to create MR based DRRs in the BEV geometry of the treatment plan. 
This would allow for image features unique to the MR modality to be combined with the 
standard CT based DRR without difficulty. This latter feature has been implemented by the 
author in the extended version of the DRR program. 
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Figure 13. Illustration of combining DRRs based on CT and MR images, 
respectively: Panel A shows a typical CT based DRR where bone has been 
enhanced. Panel B shows a corresponding MR based DRR when projecting the 
complete image volume. Panel C shows a range limited version of the image in 
B in order to improve the visualization of the contrast enhanced tumour. Panel 
D shows a combination of the image in panel A and C that can be used for set-
up verification.
 
Figure 13, panel A, demonstrates a bone enhanced CT based DRR that is appropriate for 2D 
image matching. Panel B demonstrates the corresponding MR based DRR created from a full 
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 projection of the MR volume. Even though there is a striking resemblance between image A 
and B, bony landmarks suitable for matching with an EPI are not as distinct. Panel C shows a 
range limited version of the image in B created to visualize the contrast enhanced tumour 
burden inside the MR volume. Finally, in panel D, the part of the range limited MR DRR 
enclosed by the radiation field border, is combined with image A to create an image clearly 
demonstrating the location of the tumour as well as the surrounding bony tissue.   
3.10.2. Imaging PET activity in the Beams Eye View by divergent beam geometry MIP  
Integration of FDG-PET information into the treatment planning process creates a desire to 
visualize the metabolic activity superimposed on the conventional DRR. In a full projection 
PET DRR there is an inherent danger that the uptake of FDG in healthy tissues would add up 
and diminish the visibility of, or even completely mask, tumour tissue (Figure 14, panel A). 
One method to circumvent this problem and to enhance tumour visualisation could be the 
divergent beam (BEV) maximum intensity projection (MIP). In a standard parallel projection 
MIP image, each pixel value represents the maximum intensity encountered along the parallel 
rays of projection.  In the in-house developed DRR software, the PET MIP projection is 
carried as follows: First, the PET image volume is partitioned into thinner sections or slices 
that are oriented orthogonally with respect to the central axis of the beam. Next, intermediate 
DRRs from the projection of each image section is created. Finally, a PET MIP DRR is 
created by sampling the maximum intensity from corresponding pixels (i.e. pixels in the same 
locations) in the intermediate DRRs (Figure 14, panel B). This approach is still subject to 
testing and tuning, but appears to produce PET DRRs than can improve tumour visualisation.  
A 
 
B 
 
C 
Figure 14. Illustration of DRRs based on PET images: Panel A demonstrates a full projection of the PET 
image volume. Panel B shows MIP projection of the same volume. Note the enhanced visibility of the gross 
tumour as well as positive lymph nodes. It seems that one lymph node (lower left nodule) was missed by the 
treatment beam. Panel C shows the DRR of the FDG uptake encompassed by the GTV that was outlined in the 
transversal PET images, superimposed on the corresponding CT based DRR.
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 Another visualisation technique that has been implemented is to superimpose the 
projection of the PET activity included in the tumour outlined on PET images, on the DRR 
created from the standard CT based DRR (Figure 14, panel C). This is used to display how the 
treatment beam relates to a given tumour outline defined by PET.  The latter has relevance to 
the study of an important problem caused by the inferior spatial resolution of the PET scanner 
(effective full width at half maximum, FWHM, is approximately 5-6 mm) and the effect this 
may have on the margins. These effects lead to uncertainties in defining the edge of the 
tumour volume. Comprehensive investigations into this field are outside the scope of this 
dissertation.  
3.11. Investigating a basis for the sole use of MRI for radiotherapy planning 
During the last decade the role of MRI in radiotherapy has gradually moved from being a 
source of diagnostic information only, to become an integrated modality of treatment 
planning. The superior soft tissue contrast provided by MRI compared with CT makes this 
modality very well suited for the delineation of tumour and organs at risk. However, MR 
images lack tissue density information and may suffer from large geometric distortions that 
impede the sole use of MRI for planning. Therefore it is customary to refer the patient to both 
CT and MR examinations, and as described above subsequently co-register the MR images 
with the CT images in the treatment planning system. This procedure thus facilitates target 
delineation based on the MR images and beam set-up and dose calculation based on the CT 
images.   
Clearly, a dual examination as described above may not be very cost-efficient. In 
paper VIII we therefore investigated the possibilities of using MRI as the only basis for dose 
planning alongside the DRR development that was presented above in section 3.10.1. As 
demonstrated in Paper VIII, work to perform a reliable segmentation of bone tissues and air 
pockets in the MR images would be warranted in order to make possible a calculation of 
satisfactory dose distributions. Ultrafast MR sequences ([90]) have demonstrated that imaging 
of bone structures is possible. These images may be used to create substitutes similar to CT 
that can facilitate the formation of bone DRRs required for patient set-up verification, and 
within the same frame of reference visualize the tumour (refer to range limited the DRRs 
shown in Figure 13). Skin markers that contain both iodine contrast/lead and fatty acids may 
also be used to establish reference points.  
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 4. Summary of results 
4.1. Paper I 
A novel algorithm for generation of DRRs enabling multimodality, limited range and
maximumintensityprojections
 
Standard DRR algorithms as supplied by different vendors are not flexible enough to allow 
users to develop new modes of use of the increasing amount of image information available in 
modern radiation therapy planning and follow-up. To be able to implement such new modes 
of use, a new algorithm for creation of DRRs was developed. Flexibility was ensured through 
the use of a 4th generation programming tool, and the geometric and computational methods 
were tailored to exploit the fast vector and array processing capability of this tool.  
A key feature of the new algorithm is to transform the patient and beam geometry into 
a coordinate system that has its origin in the isocentre. Its yr-axis is parallel to the y-axis of 
the patient coordinate system and its zr-axis lies in a plane defined by the focus vector and the 
yr axis. This means that the xr axis is parallel to the surface of the virtual detector. Image 
values are sampled along lines that are parallel to this xr-axis and this choice of geometry 
greatly simplifies and speeds up integration along the fan beam lines that end up on the virtual 
detector.  
The present version of the algorithm allows for a large number of preprocessing 
options to enhance the contrast of selected tissues and other details, and information from 
several medical imaging modalities may be included into the same DRR. Furthermore, to be 
able to show details around the tumour or around a critical organ, the projection range can be 
set to only include these structures. The effect of removing other tissues is to get a 
significantly better view of the structures of interest. Another option offered by the new 
algorithm is the formation of divergent lines maximum intensity projections suitable for 
inclusion of PET and SPECT information into the BEV. Through the link to the clinical 
systems, treatment data including field outlines are easily imported. Field outlines serve as 
common reference structures for different DRRs of the same beam (scene).   
4.2. Paper II
Automatic detection of singleMLC leaf positionswith corrections for penumbral effects
andportalimagerdoseratecharacteristics
 
In this paper a novel method for the detection of MLC leaf positions from electronic portal 
images was presented. This involved a detailed study of the fundamental properties of the 
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 MLC and portal imaging device (EPID) such as the dosimetric characteristics of the field edge 
penumbra behind the leaf tips and flanges, and the corresponding signal response and 
distribution produced by the EPID. In particular, an image processing method was developed  
to identify the radiation field in the portal images from an analysis of local intensity gradients, 
and measurements were performed to relate this field edge to the MLC leaf tip position 
defined from a geometrical (light field edge) as well as a dosimetrical point of view (the 50% 
decrement line). These measurements showed that a correction term that depended on the leaf 
position was required in order to correctly relate the image intensity gradient to the light field 
(geometrical leaf tip position) and the dosimetric field edge. The magnitude of the correction 
terms varied from -0.6 to 1.2 mm. Applying the correction, the method allowed for an 
accurate determination of the MLC orientation (i.e. collimator angle), one standard deviation 
being equal to 0.5°, as well as the positions of individual MLC leaf tips to sub-millimetre 
precision, one standard deviation being equal to 0.1 mm.  Applying the presented methods, 
the MLC set-up precision of a Varian Mark 1 MLC was found to be of the order 0.1 mm.  
4.3. Paper III 
An algorithm for fast adaptive image binarization, with applications in radiotherapy
imaging
 
In this paper a novel method for adaptive image binarization was presented. Image 
binarization is one of the most important image segmentation techniques and is applied to 
enhance and/or extract image texture of great relevance in carrying out a range of image 
processing tasks such as pattern recognition or image registration. The binary image may 
represent an intermediate step in such an analysis, or simply serve as an end point that is less 
subject to user interpretation and as such facilitate a less error prone analysis process. The 
present paper demonstrated the use of adaptive binarization to extract bone ridges in 
electronic portal images (EPI) generated during external beam radiotherapy. The EPIs 
represent the BEV perspective of the patient set-up used to check and confirm the location 
and orientation of the patient with respect to the treatment beam. Adaptive binarization was 
also applied to improve readability of handwritten scanned referral documents used in 
conjunction with at teleradiology service.   
The ultimate aim of image binarization is to classify each image pixel into either one 
of two classes – typically background and foreground. The presented work addressed two 
important aspects of this process, firstly the ability to adapt the classification of a given pixel 
to the local variations in the image characteristics, and secondly the speed of the algorithm. In 
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 this context local image variations were described by grey level histograms calculated from 
the pixel values enclosed by a rectangular window that was slid across the image. The 
classification (or binarization) was realised by comparing the second moments of the lower 
(ML) and upper (MR) part of the grey level histogram, respectively, using the grey value of the 
window centre pixel as pivot point. The centre pixel was classified as background if ML < MR 
and as foreground in the case of ML  MR. The use of second moments as classification 
criterion made possible an incremental update of the histograms each time the window was 
moved. In regions with a small difference between the values of neighbouring centre pixels, 
this made possible a very fast classification scheme, especially for small window sizes 
(typically less than 20x20 pixels). 
The application of the “Second Moments Adaptive Binarization” (SMAB) technique 
to EPIs produced binary images that facilitated an intermediate visual inspection and 
interpretation of the EPIs, and that were well suited for a subsequent coregistration with a 
BEV generated reference image (e.g. a DRR) representing the planned patient set-up. The 
latter made possible the implementation of a semi-automatic patient set-up verification 
procedure.  Likewise, the resulting black/white referral documents demonstrated uniform print 
density and excellent readability less subject to user misinterpretation. 
4.4. Paper IV 
ConsequencesofleafcalibrationerrorsonIMRTdelivery
 
Intensity modulation in modern radiotherapy is to a large extent facilitated by the use of a 
MLC, either operated in a dynamic mode (i.e. the leaves are in motion while the radiations is 
on) or in static mode (i.e. combination of multiple static beam segments).  In either mode, it is 
important to maintain a high level of accuracy and precision of the leaf positioning to ensure 
correct dose to the patient. In this paper we addressed the impact on the dose distribution of 
systematic errors (i.e. all leaves are offset by the same amount) in the MLC leaf calibration. 
The IMRT treatment plans of four patients with cancer in the head and neck region were 
altered by a displacing the MLC leaf positions of all the involved segments by a fixed offset 
in order to study the consequences of such discrepancies. All leaves were either forwarded or 
retracted with respect to their planned positions by ±0.25 mm, ±0.50 mm, and ±1.00 mm, 
respectively, implying a maximum change in the segment sizes of ±2.0 mm. The resulting 
dose distributions were measured in a BEV perspective by irradiating radiographic films 
placed in a slab-like phantom that were oriented orthogonally with respect to the central axis. 
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 Subsequently the optical density was converted to dose and any discrepancy between the 
planned and measured dose distributions were assessed by a gamma index calculation. The 
results showed that by using a dose difference / distance to agreement criteria of 2% / 2mm, 
respectively, the simulated leaf pair positioning errors studied here gave rise to detectable 
dose errors. When a rejection threshold of 5% was used for the fraction of gamma index 
values higher than 1, two out the 32 plans studied were actually rejected. Typically, an error 
of ±2 mm would give rise to a median dose error of 1%.  In conclusion, an accuracy of 1 mm 
of the MLC leaf position may be required to achieve acceptable dose distributions for MLC 
based intensity modulation.   
4.5. Paper V
Theperformanceofmultileafcollimatorsevaluatedbythestripetest
 
In this paper we evaluated the set-up precision of MLCs from three different linac vendors 
(Varian, Elekta, Siemens).  A method that utilized the stripe test originally developed by Chui 
et al [91] was implemented to monitor both the short-term as well as the long-term stability of 
individual leaf positions in the three systems studied. In the BEV perspective, the stripe test 
consisted of several adjacent rectangular MLC shaped radiation fields that were used to 
irradiate an imaging plate located inside a CR cassette (Agfa CR RT1.5). The plate was 
subsequently scanned with a CR reader (Agfa CR 25) to generate a digital image. The 
distribution of the optical density formed behind the resultant penumbra of the adjacent fields 
constituted, in the first place, a sensitive tool to visually unveil leaf positioning errors.  In this 
study an image processing tool was developed to analyse the shape of the density profile 
taken along the direction of leaf travel in order to detect such errors, and to quantify 
discrepancies from the intended leaf tip position. The profile in the penumbral region should 
exhibit a nearly flat shape in case of perfect alignment of the leaves, and become increasingly 
more bumpy for larger discrepancies. A MLC vendor specific calibration curve was 
established to facilitate this analysis. The curve related the leaf positioning error to the peak 
deviation of the optical density from a flat profile. The results showed that the short term 
reproducibility of all three systems were within 0.15 mm (1 standard deviation), whereas the 
long-term stability differed considerably. In particular the Siemens Optifocus displayed a 
time-trend that gave rise to errors of the order of 1 mm.  
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 4.6. Paper VI 
Portal dose image verification: The collapsed cone superposition method applied with
differentElectronicPortalImagingDevices
 
In this paper a method for estimating the dose response of two commercially available 
electronic portal imaging devices (EPIDs) were presented and tested under clinical conditions. 
One EPID was based upon a scanning liquid ion chamber matrix and the other on a 
fluoroscopic CCD camera. A calibration procedure was devised that made it possible to 
convert readings from the EPIDs into images with pixel values proportional to the absolute 
dose in a virtual water slab located in the plane of the EPID. Local response variations were 
corrected in the images from both systems using open field fluence maps. The acquired portal 
dose images (PDIs) were compared with PDIs calculated according to the collapsed cone 
superposition method for a three-dimensional detector model based on water equivalent build-
up material. The calculation model was founded on the beam modelling and geometric 
description of the treatment unit and energy used for treatment planning in a kernel based 
system.  
For the matrix ion chamber EPID the validity of the calculation method was evaluated 
for several field shapes and thicknesses of patient phantoms at 6 MV X-rays, and for the 
camera-based EPID at 6 and 15 MV X-rays. The agreement between predicted and measured 
PDIs was evaluated with dose comparisons at points of interest and with gamma index 
calculations. The average area failing the passing criteria in dose and position deviation was 
analyzed to validate the performance of the method. For the matrix ion chamber on average an 
area less than 1 % fails the passing criteria of 3 mm and 3 %. For the camera-based EPID the 
average area is 7 % and 1 % for 6 and 15 MV respectively. The overall agreement centrally in 
the fields was 0.1 ± 1.6 % (1) for the camera-based EPID and -0.1 ± 1.6 % (1) for the 
matrix ion chamber.  
An absolute dose calibrated EPID could validate the delivered dose to the patient from 
a comparison of the calculated and a measured PDI. Differences between measured and 
planned PDI could subsequently be used to adapt the treatment plan of the remaining sessions 
in order to correct or compensate for the observed discrepancies.  
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 4.7. Paper VII 
Optimal treatment margins for Radiotherapy of prostate cancer based on interfraction
imaging
 
This paper presents a method to estimate the optimal treatment margins to achieve 
complication-free curative radiotherapy of prostate cancer. Cone-beam CT images of a 
prostate cancer patient undergoing fractionated radiotherapy were acquired at all treatment 
sessions to study inter-fraction tumour displacement and organ deformation. The clinical 
target volume (CTV) and organs at risk (OARs: bladder and rectum) were delineated in the 
images, generating a library of 3D CTV-OAR configurations. Random sampling from the 
library was performed in order to simulate fractionated radiotherapy that include the effects of  
intra- and inter-patient variability in setup and organ motion/deformation. For each simulated 
patient, four treatment fields were automatically generated around the planning CTV by the 
use of a MLC. The treatment margin, defined as the distance from the CTV to the field 
border, was varied between 2.5 and 20 mm. Dose distributions were calculated by the 
application of a convolution method. To accumulate or track the doses to OARs (experiencing 
inter fraction deformations), the session specific bladder and rectum dose distributions were 
reconstruction in the planning CT geometry by the application of polynomial warping. The 
CTV (experiencing inter fraction displacement) was assumed to be a rigid body and the 
corresponding dose distribution were tracked using a simple translation of the session specific 
dose distribution. The equivalent uniform dose (EUD), the tumour control probability (TCP) 
and the normal tissue complication probability (NTCP) were used to estimate the clinical 
effect of a given dose distribution. 
The simulations produced population based EUD histograms for the CTV and the 
OARs. The number of patients receiving an optimal target EUD increased with increasing 
margins, but at the cost of an increasing number receiving a high EUD to the OARs. 
Calculations of the probability of complication-free tumour cure and subsequent analysis gave 
an optimal treatment margin of about 8 mm for the simulated population. 
The current work illustrates the principle of obtaining optimal treatment margins based 
on both tumour and normal tissue characteristics. However, a larger patient image data base 
must be assessed in order to estimate clinically applicable margins. 
 
 
 
 50 
 4.8. Paper VIII 
A simulation of MRI based dose calculations on the basis of radiotherapy planning CT
images
 
The superior soft tissue contrast of MR images compared to CT images has spurred the use 
this imaging modality for radiotherapy treatment planning, primarily to facilitate the process 
of delineating volumes of interest (VOI). However, MR images as such lack tissue density 
information and may also suffer from various geometric distortions. These properties hamper 
the direct use of these images (and the associated VOIs) for dose calculation. To circumvent 
these problems, the MR images are traditionally coregistered and subsequently blended with a 
CT study acquired for dose planning. Evidently, this process is potentially cumbersome and 
time consuming. In this paper we therefore addressed the potential sole use MR images for 
planning. We investigated the effect that different segmentation strategies, and associated 
selection of representative uniform densities for the segmented tissues, could have upon the 
calculated dose accuracy as compared to a fully CT-based calculation.  
This was achieved by manipulating the densities of the CT images that formed the 
base data of the treatment plans for 10 patients referred to external beam radiotherapy of 
prostate cancer. The images were segmented into water and bone equivalent tissues by a 
simple thresholding of the Hounsfield values. A dose calculation was then performed using 
the segmented images. At the same time we scored the dose volume statistics of three 
different volumes of interest (CTV, bladder, rectum).  In doing so, we could simulate MRI 
based dose calculation and evade issues related to MRI tissue classifications and any impact 
of MR image distortions. In addition, this facilitated a point by point comparison of the dose 
distributions for various tissue segmentation strategies to the plan applied clinically.  
The results indicated that to achieve a dose calculation accuracy of the average dose in 
the CTV comparable to the plan applied clinically (relative mean difference of 0.2 ± 0.2 %), 
the images had to be segmented into water and bone equivalent tissues, with densities of 
1.03g/cm3 and 1.3g/cm3, respectively.  
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5. Discussion
5.1. Introductory remarks 
The work presented in chapter 3 and in the papers was undertaken to investigate techniques to 
improve the geometric and dosimetric precision of external beam radiotherapy (EBRT). This 
work rests heavily on the development and implementation of image processing techniques 
mainly applied to the BEV geometry. In addition aspects of system architecture and network 
communication have been addressed. The strong focus on sophisticated computer 
programming was recognized as a prerequisite in order to handle the immense amount of data 
produced.  
The present system is a result of a continuous development in the Norwegian Radium 
Hospital through more than a decade. The suite of methods and programs has been used to 
carry out quality control of beam limiting devices and patient treatment procedures. In 
particular, new imaging technology and the ability to - on a daily basis - assess set-up 
uncertainties in individual patients have brought a new understanding of the degree of 
precision that can be achieved with EBRT. This work has facilitated sound decision making in 
the everyday routine, and the clinical “best practice” has moved from the cm scale to the mm 
scale.  
The beams eye view represents an excellent and intuitive display mode that can show 
images that share a common frame of reference and that can comprise a multitude of 
information vital to many phases and aspects of radiation therapy such as anatomy, 
(molecular) biology, functionality, dose, organ motion, and treatment response. The BEV 
provides convenient means for monitoring and visualizing discrepancies between actual and 
planned therapy as well as providing perceptive demonstrations of how inter- and intra-
observer variability affect  beam size and hence the volume of irradiated tissue.  
The field of image based verification and image guided radiotherapy has matured 
dramatically in the years following the initial RTNavigator investigations and developments 
carried out by the author. Extensive scientific efforts within numerous research groups and 
among vendors have produced great achievements and advances in treatment quality. Below 
follows as an introduction a sketch of some of the weaknesses and problems of the BEV 
geometry. Then follows a brief synopsis of developed the most important recently 
technologies and methods, and their relationships to the BEV techniques.  
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 5.2.  Weaknesses of imaging in the BEV geometry
Each pixel value of the 2D image that results from a BEV projection represents the line 
integral of voxel values present in a 3D image volume. In the case of the formation of a DRR 
(full or limited range projection) this is the outcome of a mathematical process, whereas in the 
case of an X-ray image (e.g. an EPI) this is the result of a physical process - mainly due to 
attenuation of radiation in the body. In the latter case, image quality (contrast and geometric 
resolution) is deteriorated by the effects of scattered radiation and the finite size of the 
radiation focus. In addition, the attenuation coefficients of bone and soft tissue are closer for 
the high photon energies used in radiotherapy compared to the energies typical of diagnostic 
X-ray imaging. The resulting lack of recognizable fiducials means that image registration 
must be based on fragments of structures scattered over the image surface. The best match to 
these structures is not necessarily unique [92]. From the experience gained in the present 
work, and in the work of others, a human verification of the registration outcome is thus 
required.  
The apparent added complexity caused by the collapsed BEV geometry may impede 
the intuitive interpretation of what is observed. Furthermore, the computer programs possess 
no a priori ability to make sense of the globally discernable patterns, and sophisticated pattern 
recognition methods may be needed. 
5.2.1. Problems connected to alignment and registration in the BEV geometry 
The correct alignment of a patient on the treatment couch constitutes a three-dimensional 
problem (or even a 4D problem) [93].  The comparison of portal with reference images in 2D 
sometimes yields insufficient information to establish a complete correction of the set-up in 
3D [92].  Evidently, the BEV geometry of the EPI has shortcomings when it comes to the 
ability to assess out-of-plane rotations, i.e. rotations of the patient along axes that are not 
perpendicular to the image plane. Objects closer to the focus will, because of rotations, show a 
larger shift in the 2D image than objects close to the EPID, and may suffer from distortions 
due to the shifted perspective. In theory, this effect may be mitigated if the mutual distances 
are known, but this is rarely the case in clinical practice. Likewise, geometrical degeneracy in 
the alignment of rotationally symmetrical objects, like the femoral heads, often in 
combination with poor tissue contrast, may cause ambiguous 2D alignment from a single view 
(if possible such structures should not be used for image matching). As a consequence, 
analysis in 2D can only provides accurate measures of patient set-up deviations when such 
rotational errors are small. Studies have demonstrated that in the treatment of the prostate 
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 cancer, out-of-plane rotations larger than 3 degrees of the pelvis may cause significant 
misinterpretation of the position of the isocentre inside the patient if interpretation is based on 
2D images only [92].   
5.3. The introduction of the in-treatment-room Cone-beam CT  
The most striking technological accomplishment during the past decade is probably the advent 
of in-treatment-room volumetric kV-imaging. By applying a conventional X-ray tube and an 
EPID like flat panel imager mounted on the treatment gantry, 2D X-ray images can be 
acquired at a frame rate of typically 3-6 frames/sec as the gantry of the treatment unit rotates 
around the patient. A modified filtered back projection algorithm is then applied to reconstruct 
an image volume from these 2D images [20, 94-95]. The reconstructed images exhibit 
features comparable to that of conventional CT images: high spatial resolution (voxel size of 
1x1x1 mm3) and good soft tissue contrast at low radiation doses. The CT like images have 
given rise to the acronym kV CBCT (kilovolt Cone-beam CT). The implementation of this 
technology has been instrumental in order to surmount some of the key problems of 
conventional MV based EPIs that may hamper image registration and degrade the effort of 
image guidance.  
Cone-beam imaging has also been developed that utilizes the megavolt energy 
radiation and the standard EPIDs of the treatment unit (MV CBCT) [96-99]. However, the 
lower detector quantum efficiency as well as lower tissue contrast of the images produced, 
may pose some limitations on the clinical usefulness of this imaging technique compared to 
kV CBCT.  On the other hand an advantage of the MV CBCT technique is the inherent 
reduction of image artefacts due to high Z materials such as dental fillings and prostheses. In 
addition, the images constitute a direct measure of how much the treatment beam is attenuated 
by the patient. As such the MV CBCT can readily be used for treatment planning and 
calculation and verification of dose without the need of a tabular conversion of the voxel 
values into a measure of electron density [100].    
To get the most out the CBCT images, i.e. a quantification of the true set-up deviations 
in 3-D, methods to co-register the full CBCT data set and the planning CT have been 
developed. A mutual information criterion based on the grey values with no need for user 
defined templates, is frequently used. Alternatively, a 3D chamfer matching technique can be 
used where the extracted skeleton (or implanted fiducials for that matter) of the CBCT data is 
matched to the corresponding distance transform of the skeleton (fiducial) of the planning CT. 
The superior soft tissue contrast of the kV CBCT images has also made possible image 
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 registration directly on tumour tissue. The latter has been reported for example for the 
treatment of prostate cancer [101] and stereotactic radiotherapy of non-small cell lung cancers 
[102]. These methods enable a very precise quantification of set-up deviations both wrt to 
translations (Tx,Ty,Tz) and rotations (Rx, Ry, Rz).  
Unfortunately, widespread access to satisfactory table top “mechanics” that facilitates 
6D corrections of the patient pose is still scarce and is yet subject to clinical investigations. A 
few “roll and tilt” tables have been put into clinical use, but a comprehensive corrective action 
to account for the 6D set-up deviation vector is still in its infancy.  
Non-rigid anatomy such as that found in the neck region, anatomy that easily moves 
about such as extremities, or tumours located close to or even inside moving organs such lung 
or liver tumours, can jeopardize the usefulness or correctness of the proposed 3D/6D 
registration metric in CBCT applications. To alleviate this problem, vendors have introduced 
clip boxes (one or many) or various types of image segmentation techniques that enables the 
user to include in the registration, only the subsets of image data that are believed to be rigid 
and of relevance to the treatment.   
Recently, 4D CBCT imaging has also been made possible [103-104]. In this context 
4D images relates to successive volume displays of the movements of the tumour and internal 
organs as a function of time. Alternatively, techniques to estimate the respiratory motion have 
been developed that subsequently have made it possible to correct for the motion effects 
during the reconstruction of the 3D CBCT images (motion-compensated CBCT or MC 
CBCT) [105-106]. These developments have aimed reducing the uncertainties and streak 
artefacts induced by respiratory motion that can jeopardize the clinical usefulness of the 
images. 
In cases of non-rigid anatomy deformable registration algorithms, such as the “demons 
algorithm” [107-108], have been implemented and tested to improve the 3D registration 
accuracy. The key objective of this development is not to estimate set-up deviations to be used 
for corrections, but more importantly to make possible a correct summation of dose delivered 
on different sessions given the actual pose of   the patient. This is an important prerequisite for 
adaptive radiotherapy. Still, elastic (non-rigid) tissue (tumour) and patient body deformation 
will continue to challenge the accuracy and precision of the treatment and is expected to be an 
active area of research in the future. 
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 5.3.1. Imaging in the Beams Eye View in combination with CBCT systems 
Evidently, the 2D X-ray images created with the use of the X-ray tube of the kV CBCT 
system can play the role of the megavolt EPIs. A popular mode of operation is the acquisition 
of two orthogonal (or nearly so) X-ray images that are compared with DRRs created from the 
planning CT. This procedure has proven to be fast and straightforward, the superior tissue 
contrast inherent to X-ray images is maintained, and a large field of view can be used with 
negligible extra dose given to the patient. These factors all contribute to make the image 
registration fairly trivial. The stereoscopic (2D/3D) set-up verification can be performed by 
the use of either bony structures or implants as a fiducials, or by application of a mutual 
information criterion. By use of this technology automated and nearly real time registration 
seems achievable with satisfactory precision and consistency for a number of clinical 
scenarios. The technique has lately been extended to allow for tumour motion tracking during 
thoracic and abdominal radiotherapy [109].   
Tumour motion during radiotherapy treatment delivery can substantially deteriorate 
the target dose distribution. The above mentioned technique has lately been extended to allow 
for tumour motion tracking during thoracic and abdominal radiotherapy [109]. The BEV 
perspective is used to identify the tumour position from projection images acquired during
treatment and subsequent feed this information back into the MLC controller. At present, the 
tracking system latency, i.e. the time lag between the target motion and the correcting beam-
target re-alignment, must be reduced in order for this concept to be clinically applicable. 
However, several groups have tested and demonstrated that it is feasible within seconds to 
reposition the MLCs according to the position of a tumour marker detected in a series of EPIs 
(Micropos). This development involves field edge detection in dynamic images and dedicated 
image segmentation methods to identify and describe the motion pattern of the tumour. The 
various BEV concepts studied and developed within the present NRH project can be extended 
to also handle tumour tracking.   
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6. Conclusion: Imaging and image processing in the Beams Eye View 
perspective
The work presented in the present dissertation has taken place in a clinical environment, and 
has benefited significantly from an enduring feedback from clinicians, medical physicists, and 
radiotherapy technicians. Such a process is unquestionably fundamentally different from an 
industrial development of software for radiotherapy. The latter would not be able to 
incorporate the many logistically complex interrelated activities that take place in the in the 
radiotherapy clinic. The scientific efforts were thus translated into thoroughly tested working 
modules that supported the logistically intricate interplay between systems and radiation 
therapy professionals. Evidently, some of the experiences gained by other groups were 
implemented in the IBV software, and some were developed in-house for specific purposes, 
most of which have been described in chapter 3. 
The effort put into achieving high-quality external beam radiotherapy includes a large 
number of complex actions where each and every one is associated with a range of 
uncertainties. These uncertainties can be detrimental to the clinical efficacy of the dose that is 
deposited within the body of the patient during irradiation. Evidently the key notion of image 
guided radiotherapy is to minimize such uncertainties in order to optimize the treatment 
efficacy and thereby improve patient outcomes [110].    
  The present work has demonstrated the importance of the BEV concept for ensuring 
the geometric and dosimetric precision in external beam radiotherapy. The presented methods 
and processing techniques which have been implemented in the clinical setting have improved 
the quality of the treatment. This can be illustrated in the following ways:  
At the time this project started in 1992 typically one or two portal films were exposed 
during each course of treatment and a visual inspection of the films on a light box was 
conducted. A visual judgement of the set-up accuracy was carried out keeping in mind that 
rather generous CTV-PTV margins – often of the order 1 cm - were used. The average 
number of treatment fields per target volume was slightly larger than 2 and CT based planning 
was used for around 20% of the patients. Digital imaging and imaging technology in the field 
of radiotherapy was literally in its infancy.  
Since 1992 the complexity of a treatment plan has increased significantly. The average 
number of fields per target volume is now around 5 and for nearly 90% of the patients there 
exist a CT based treatment plan. Improved access to radiological imaging modalities in 
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 treatment planning (i.e. more precise tumour delineation) has led to narrower treatment 
margins and in some cases made possible an escalation of the target doses. Obviously, the 
increased complexity and smaller margins entails a greater risk of both geometric and 
dosimetric misses. The presented work has been instrumental in gaining the required insight 
and awareness of the uncertainties that materialize in daily practice to counter-act any such 
potential increased risk. The new tools developed have enabled the staff to quantify and 
mitigate detected set-up errors systematically, efficiently, and with confidence.  
Today the number of portal image acquisitions can be in the range 20 to 60 images 
during a treatment course – the latter number representative of daily imaging of head and neck 
patients treated with IMRT. Likewise, with the use of implanted markers in the prostate 
combined with daily orthogonal imaging (or kV CBCT), CTV-PTV margins as small as 2-5 
mm have been feasible, and target doses of 78 Gy can safely be administered.  
The systematic use of imaging and the knowledge gained thereof, was a prerequisite in 
assuring the treatment precision required when IMRT was implemented in the department 
more than 10 years ago for the treatment of head and neck cancers. Consequently an extensive 
off-line imaging protocol by the use of IBV was put into use to address the systematic errors 
that were regarded most important in such a highly fractionated type of treatment [111-112].      
Recently the knowledge of and access to image guidance has been critical to the 
introduction of treatment options such as stereotactic radiosurgery of brain and lung lesions, 
as well as hypofractionated stereotactic radiotherapy of spine, lung and liver without the use 
of rigorous body frame fixation. For such treatments of large doses in a single or a few 
fractions, the random component of the set-up error is most important [63, 113] and an on-line 
image based set-up verification protocol is standard clinical practice.   
The knowledge gained and tools developed for imaging in the BEV perspective in this 
project, has increased our confidence that the treatment is carried out according to the plan, 
i.e. that intended dose is delivered to the target, and has been vital to safe and sound 
introduction of new sophisticated treatment techniques.  Nowadays the question is no longer 
“whether” imaging is needed, but rather “how much”.   
6.1.  Future prospects 
For many years, radiotherapy strived at perfecting the treatment of the static, “dead patient”, 
improving the physical basis of the treatment, for instance through the development of photon 
based IMRT and intensity modulated proton therapy, to achieve outstanding geometric (and in 
2011 arguably sufficient) dose conformity.  
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 Clearly improved 4D characterisation of the tumour, anatomically and physiologically, 
and a capability to quickly redesign and adjust treatment plans from measurements of 
treatment response, are prerequisites in order to further enhance the efficacy of radiotherapy 
(i.e. cell kill for a given dose). This can only be accomplished by relating imaging and 
imaging technology intimately with the radiotherapy process. The minimum desirable 
irradiation dose (and possibly the maximum acceptable dose) may ultimately be prescribed 
from an image that describes tumour aggressiveness (dose painting by numbers). New 
technologies that facilitate such a development are currently being investigated or even being 
developed. Examples are a combined MRI and PET modality that makes possible 
simultaneous measurements of anatomy and physiology [114]; integrated MRI and linear 
accelerators (MRIgRT) [115-117] that allow for millimetre precision in dose delivery guided 
by the superior soft tissue contrast of MR images, whole body PET/CT machines and real 
time tracking of tumour motion using fluoroscopy. 
The next logical step into further improved treatment efficacy would be to examine 
and describe the dose distribution that results from treating an elastic, “live” patient and 
tumour, with these highly conformal techniques. Secondly, to account for any observed 
clinical response effects and adapt the remaining treatment accordingly. The synergy of recent 
efforts and advances in functional and molecular imaging and deployment of 3D/4D IGRT, 
may provide the means to move radiotherapy this step forward.  
My view is that even after the introduction of multi-dimensional imaging, the BEV 
will continue to play an important role. In future developments the BEV may prove to be for 
the clinicians the most viable technique to provide an intuitive and instructive visualization of 
the complex multi-parametric information that enters radiotherapy planning and follow-up.  
The BEV constitutes an important tool for treatment planning and plan validation (DRRs) and 
for the verification of the treatment delivered (EPIs / PDIs). The BEV is as such an important 
instrument for ensuring as well as improving the treatment quality.  
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